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Abstract: Bicyclic molecules with the I ,7-dia2a-6 ,6-dimethylbicyclo[2 .2 .llheptane and l,8-diaza-7,7-dimethyl- 
bicyclo[3.11Joctane (l-aza-7/Mimethyltropane) skeleton are shown to be efficiently synthesized via cyclization 
reactions of endocyclic tf-acylhydrazonium intermediates. By using a protected p-ketoester as the internal nucleophile, 
azacocaine analogues are also accessible via this methodology.
INTRODUCTION
The synthesis of bicyclic hydrazines with a l,7-diazabicyclo[2.2.1]heptane or a 1,8-diazabicyclo- 
[3.2.I]octane skeleton {e.g. 1 and 2, respectively) has received only scant attention in the literature* The 
structures with the heptane skeleton arc particularly interesting compounds as both the N-chloro and //-methyl 
substituted molecules have been reported to exhibit high nitrogen inversion barriers for the bridge nitrogen 
atom.1-3 A noticeable feature of the second types of compounds is that they possess a 1-azatropane skeleton and 
therefore might display promising physiological activity. During the last century, tropane alkaloids have been 
prominent targets in organic synthesis, both for their biological properties and in order to elucidate their 
mechanism of action.4 The most distinguished class of tiopane alkaloids consists of cocaine and its isomers, of 
which various analogues have been prepared.5 The synthesis of azaanalogues 3, however, has not been reported
in the literature.
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A method for the preparation of some bridged bicyclic hydrazines 1 and 2 was developed by Oppolzer,6 
who obtained such compounds via intramolecular 1,3-dipolar cycloaddition reactions. In addition to this 
method, intermolecular dipolar reactions have been studied to give a limited number of 1-azatropanes.7*8 A 
serious set-back of these methods is the limited possibility to vary ring sizes and substitution patterns. Herein 
we wish to Teport a novel pathway for the preparation of such compounds, offering the possibility of 
synthesizing differently functionalized bridged diazabicycles.
A retrosynthetic outline of the method, which extends our previous work on W-acylhydrazonium ions,9
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is given in cq 1. The key intermediate is the endocyclic JV-acylhydrazonium ion 5, which is converted via 
intramolecular attack of the internal nucleophile into the tricyclic product 4, The precursor 6 of the tf-acyl- 
hydrazonium intermediate 5 is readily obtained in a few steps starting from the corresponding pyrazolidinonc 7 
or 8. A large variety of ^ -nucleophiles can be used in this cyclization reaction to give the desired functionalized 
bicyclic products. The use of a (protected) (3-ketoester as nucleophile in the cyclization reaction leads to 
precursors with a substituted tropanone skeleton* Regarding the ongoing search for new cocaine analogs, it is 
relevant to note that our method might provide a route to such compounds.
6 7 R 
8 R
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Me
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RESULTS AND DISCUSSION
Choice of the pyrazolidinone
The use of unsubstituted 3-pyrazolidinone (7)10 as starting material will lead to unsubstituted bicyclic 
hydrazines 4 (R = H). In order to study the sequence of reactions, l-benzyl-3-pyrazolidinone10c was chosen as 
a model system. Ethoxycarbonylation {1) LDA (1 equiv), -78 *C; 2) methyl cyanoformate (1.3 equiv)) gave the 
functionalized hydrazine 10, which had to be reduced to obtain the cyclization precursor 9 (eq 2). The reduction 
was performed under conditions that were also used for the corresponding pyrrolidinones.11 Treatment of 10 at 
-20 *C in ethanol with an excess of sodium bomhydride (4 equiv) and a catalytic amount of sulfuric acid, 
however, led to ring opening of the pyrazolidinone and subsequent reduction of the intermediate aldehyde to the 
alcohol 11. Formation of this undesired product could not be prevented by performing the reaction at lower 
temperatures. Reduction did not take place at all in the absence of acid.
CO*Me
NaBH4, H+(cal)t
CQMe
10 (40%)
-78 ’C, EtOM MeOfeC
(2)
1 1  (80%)
The undesired ring opening and overreduction are not expected to occur if the pyrazolidinone ring is 
substituted with a gem-dimethyl function (i.e. 8). The effect, that alkyl substitution favors the cyclic structure in 
cases of ring-chain tautomerism* is an example of the well-known ‘gem-dimethyl effect’12»13 and was observed 
earlier in similar pyirolidinone systems.14 Therefore, 5,5-dimethyl-3-pyrazolidinone (8) was chosen as starting 
material and could be efficiently obtained by condensation of hydrazine hydrate with ethyl 3,3-dimethylacryIate 
in refluxing ethanol.15 Distillation of the crude residue gave the pure 3-pyrazolidinone 8 as a colorless oil (bp 
100-105 *C, 0.1 mbar), which solidified upon standing.
The series of reactions that lead to the desired cyclic molecules is exemplified in Scheme I. The alkylated 
product 12 is obtained upon SN2-alkylation of 8 with benzyl chloride {(1.2 equiv), lithium iodide (cat), 
potassium carbonate (1*5 equiv), 2-butanone, reflux}. In this alkylation reaction, the different nature of the two 
nitrogen atoms was very important. The N1 nitrogen is an amine type nitrogen atom, which is more prone to 
react with the halide than the less nucleophilic amide type N2 nitrogen. The alkoxycarbonylation at the N2 atom 
can in principle be achieved by using one of the five different methods A to E: A) deprotonation with a strong 
base (sodium hydride (1.05 equiv), rt) and alkylation with methyl chlorofoimate (1.2 equiv, 0 *C rt) in THF;
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B) the same procedure as A with ethyl chloroformatc instead of methyl chloroformate; C) treatment with diethyl 
dicarbonate (2.0 equiv, rt) in the presence of triethylamine (1 equiv) and DMAP (1 equiv) in dichloromethane;16 
D) deprotonation with LDA (1.1 equiv, -78 *Q, followed by methoxycarbonylation with methyl cyanoformate 
(2 equiv, -78 *C rt) in THF;11 E) deprotonation with sodium hydride (1.1 equiv, rt), then reaction with 
methyl cyanoformate (2 equiv, -78 *C —> rt) in THF. The disadvantage of the first two alkoxycarbonylation 
methods is that a mixture of the N- and O  alkylated product (13 and 17, respectively) was obtained.17*18 The 
selectivity of this reaction could not be influenced by changing the temperature of the reaction. The formation of 
the O-alkylated product was indicated by a strong absorbance in the JR spectrum at 1630 cm' 1 as a result of the 
presence of the C=N bond.17
Scheme I
method C 
(see text)
1 2  (80%) 
method B (see text)
0 C 0 2Et
17 (39%) and 13 (59%)
13(81%)
1) NaBH*, H+(cat), 
-20 '0 , EtOH
2) 2 M H2S 0 4/Et0H
KOH (4 equiv) 
MeOH, reflux
14(90%) TtCU (2 equiv), 
■78 C rtj
ch2ci2
16(81%) 15(62%)
Reduction of the pyrazolidinone 13 under ‘standard conditions*11 initially afforded the corresponding 
hydroxypyrazolidine, which was directly converted into the ethoxypyrazolidine 14 by stirring in acidic ethanol. 
This last step already indicates the intermediacy of the endocyclic N -acylhydrazonium ion. Cyclization to 15 
took place upon treatment with titanium tetrachloride. The free hydrazine 16 was obtained through hydrolysis of 
the carbamate function with potassium hydroxide in refluxing methanol.1^
Synthesis of bridged bicyclic hydrazines via Lewis acid-mediated cyclizations
A summary of this scries of reactions applied to differently alkylated pyrazolidinones is presented in 
Table I. Generally, the aforementioned alkylation conditions were found to give fair yields with several 
alkylating agents. The low yield in the case of propargyl bromide (entry 12) was explained by the formation of a 
considerable amount of the dialkylated pyrazolidinone 22 a (30%). It was also shown that use of an excess of 
the alkylating agent led to the formation of the dialkylated product. For example, if 1.5 equivalent of allyl 
bromide was added, a substantial amount of the diallylated product was also found. The pyrazolidinone 24 
(entry 16) was obtained upon alkylation with 4-iodo-l-(trimethylsilyl)-2-butyne,20 which was prepared via the 
corresponding mesylate.21 The dioxenone substituted pyrazolidinone 25 (entry 19) was obtained after alkylation 
with the corresponding chloride,22 The relatively low yield of the alkylated product 25 is explained by the 
thermal instability of the dioxenone moiety. This result was obtained after stirring in acetone at 40 *C for 40 h. 
Both higher and lower temperatures showed a decrease of the yield of 25.
As can be seen from Table I, alkoxycarbonylation methods A and B suffer from the formation of O- 
alkylated products (entries 2, 7 and 10). The lack of regioselectivity could be overcome by using the more 
selective reagent methyl cyanoformate, instead of methyl or ethyl chlotoformate (entries 11,18 and 20).2-* The 
alternative method C, in which the use of a strong base is avoided, also gave satisfactory results (entries 3, 8 
and 15). Although this reaction does, in principle, not require a base, the best results were obtained by using 
stoichiometric amounts of Et3N and DMAP.
Reduction of the pyrazolidinones proceeded without difficulties in reasonable to good yields in all cases.
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The hydroxypyrazolidincs 42 and 43 were isolated only in the case of the allyl- and propargylsilanes 34 and 35 
(entries 15 and 18). This was done in older to prevent protodesilylation under the acidic conditions that are 
required for the hydroxy/ethoxy exchange.
Table I. Synthesis of bridged hydrazines via Lewis scld-medlated cyclization*.
alkylated product (yield) 
entry acyiated product(s) (method* yield)
reduction 
product (yield)
Lewis cydization 
acid products (yield)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
R
10 Rm H (66%);
27 R -  CO*Et (C- 82%)
T j Y
1 « R -  H (8 8 %),
28 R -  COaMe (A: 74%)
OCOjMe 
26 (A* 33%)
O 
20 R
"R
H (61%),*
30 R *  CO£t (C: 64%)*
OCOjMe 
29 (A* 47%)*
O
21 R 
31 R 
31 R
"R
OCO^a
H (82%);
CO ^e (A. 24%) 32 (A: 18%) 
COjMe (D: 93%)
22 R -  H (40%)J*
33 R *  COaEt (B‘ 67%)
23 R « H (83%),
34 R -  COjEt (C‘ 62%)
EtO
vCOaEt
37 (83%)
r f
COjMe
38 (75%)
EtO
39(71%)*
EtO
CpaMe
40(44%)
'CC^ Et
41 (65%)
T1CI4
45 (95%)
TlCt,
TiCU
T O
TiCU
46 (56%) 47 (16%)
BF3 -OEt2
42 (96%)
EtQaC
N
Cl
48(53%)
MeOsC
H  C l
49(84%)
EtOzC
N
50 (24%)
Cl
EtOoC
N
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Table I. Continued
16
17
18
19
20
24 R -  H (B8%);
35 R - COfcMe (A: 62%) 
35 R - COjMa (D: 53%)
H (61%);
CC^ Me (E: 68%)
BF3OEta
43(59%)
EtO
BFS OEta
44(68%)
a) Obtained as a 3 3 1 f/Z-nrwxture b) 22a R -  CH2OCH was also found in 30% yield
MeOtC
53 (04%)
The cyclization reactions were performed under standard conditions with the Lewis acid titanium 
tetrachloride (2 equiv, dichloromethane, -78 *C rt) and in the case of the silanes 42 and 43 with boron 
trifluoride etherate (2 equiv, dichloromethane, 0 #C rt). For the cyclization reactions in entries 3 ,5 ,8  and 11 
tin tetrachloride was also tried as the Lewis acid but gave lower yields. Treatment of 37 with titanium 
tetrachloride afforded the bridged hydrazine 45 in a good yield (entry 3). Its stereochemistry was established by 
using NOE-difference *H NMR techniques on the corresponding free hydrazine 60 (see eq 4), Irradiation of the 
endo-Me signal of 60 gave a strong enhancement of the signal of the proton adjacent to the chlorine atom. This 
is only possible if the six-membered ring is in a chair conformation with the chlorine atom in the equatorial 
position. Such a configuration is in agreement with the expected mechanism for a cationic olefin cyclization,24 in 
which the ring closure takes place via a chair-like conformation 54» and chloride comes in from the equatorial 
side (eq 3, R = H). The assignment was confirmed by the NMR spectrum of 60, in which the signal of the 
hydrogen atom adjacent to the chlorine atom (4.20 ppm, tt) showed two axial-axial (^ Jaa * 11.1 Hz) and two 
axial-equatonal couplings (3/-_ = 6,3 Hz),
i
N
+ C 02Et 
54
EtOp Et02C<
cr
45, fi -  H 
43, R « Me
Cl (3)
The above reasoning also explains the stereochemical outcome of the cyclization of the croty! precursor 
39 to 48 (entry 8), in which both substituents occupy the equatorial position. In the conformation leading to the 
transition state of the (£)-precursor, the methyl group is in the equatorial position (54, R *  Me), while chloride 
attacks from the equatorial side, thus giving rise to the formation of the fra/ir-pioduct 48 as the only product 
The (Z)'isomer would lead to a transition state with the methyl group in the axial position, so that cyclization to 
the cis-product would take place. However, this product was not observed in the reaction mixture. The relative 
configuration of 48 was inferred from the splitting pattern of the *H NMR signal of the proton adjacent to the 
chlorine atom (3.76 ppm, dt) showing one eq-ax (V ^  = 6.3 Hz) and two ax-ax couplings (V ^ «  10.8 Hz).
Cyclization of the methallyl precursor 38 (entry 5) afforded an inseparable mixture of 46 and the 
elimination product 47. The stereochemistry of the product 46 could not be fully ascertained, but it is most 
likely that the methyl substituent is equatorial in view of the severe steric interaction between the two endo- 
methyl groups in the alternative stereoisomer. The crowded nature of the product is reflected in the formation of 
a relatively large amount of the elimination product 47. Because the double bond causes the six-membered ring
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to flatten, a favorable conformation is obtained in which the interaction of the substituents with the carbamate 
function and the ertdo-methyl group is decreased.
Upon cyclization of precursor 40, the l,7-diazabicyclo[2.2.1]-heptane 49 was formed as a single 
product in high yield (entry 11). The bulky substituent is in the exo-position, which was concluded from the 
splitting pattern of the signal of the bridgehead hydrogen atom (4.43 ppm, d, = 4.9 Hz),2 The coupling 
constants of the bridgehead proton with both adjacent ertdo-protons are zero as a result of dihedral angles of 
approximately 90 \
The less nucleophilic acetylene 41 cyclized in a rather low yield (entry 13). This can be either a result of 
the poor nucleophilicity of the acetylene or of the instability of the product 50. Both silanes 42 and 43 cyclized 
in reasonable yields to give the elimination products 51 and 52.
In addition to these results, the dioxcnone precursor 44 led to the expected cyclization product 53 in a 
high yield. Although many conditions were tried, cyclization took place only after treatment with boron 
trifluoride etherate (4 equiv). A smaller amount of this milder Lewis acid led to an incomplete conversion of the 
precursor 44 into the cyclization product 53. The use of tin tetrachloride or titanium tetrachloride led to 
decomposition of the dioxenone moiety prior to cyclization.
Tab)« II. Formic acid-mediated cyclization reactions.
entry
1
6
precursor
'à y
r
c o 2 m« 38
y
EtO
'COaM« 40
^COjEt 41
EtO
' Ù Xf  CO,Et
HO
?
sim«3
42
COjMe
S1M63
43
'Ç r c f *
EtO
condition« cyclization product(s) (ylekl)
MeO aq
18 h, 50 *C
KfoQzC
56 (37%)
HCHO
47 (34%)
18 h, 50 ‘C
18 h, 50 'C
18 h, 25 'C
18 h, 50 *C
5 h, 100 ‘C
MeOjC
N
57 (84%)
OCHO
EtO¿C
58(47%)
O
EtOjC
51 (85%)
MeQjC
MeOjÇ W
52(42%)
59 (42%)
O
a) After the reaction, water was added and the mixture was stirred for 6  h at 60 ‘C.
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Formic acid-mediated cyclizations
Compared with the yields of the Lewis acid cyclizations, slightly different yields were obtained as is 
evident from Table II. The stereochemical outcome is similar compared to the Lewis acid cases. In the cases of 
the precursors 14, 37 and 39 , cyclization did not take place, but instead the ethoxypyrazolidines were 
converted into the corresponding hydroxypyrazolidines (not shown in the Table). This is somewhat remarkable, 
as during work-up the use of water is avoided. Presumably, the formyloxy group was exchanged during flash 
chromatography to give the more stable hydroxypyrazolidines. From the formation of the hydroxypyrazolidines 
it is evident that the N-acylhydrazordum ion was formed, but that cyclization did not take place. These results 
emphasize that formic acid is less suitable for the cyclization reactions than Lewis acids. For precursor 37, other 
acidic conditions were also tried e.g. trifluoroacetic acid in dichloromethane, formic acid at 100 *C, hydrogen 
chloride in methanol, and trimethylsilyl triflate, but none of these conditions proved to be successful. An 
example that nicely illustrates the usefulness of these formic acid cyclizations is presented in entry 3, in which 
the propargyl precursor 41 cyclizes to give the 1-azatropanone 58 in one step via hydrolysis of the intermediate 
enol ester. Surprisingly, a similar ketone was obtained in an attempt to cyclize precursor 44 (entry 6). While at rt 
and at 50 *C only starting material was recovered, reaction at 100 ‘C led to cyclization, immediately followed by 
ring opening of the dioxenone moiety and decarboxylation to give 59.
Deprotection reactions
The cyclization products 45 and 51 were deprotected to give the free hydrazines 60 and 62, 
respectively (eqs 4 and 5). Two methods were applied i.e. hydrolysis under basic conditions (potassium 
hydroxide in methanol)1^  and cleavage with iodotrimethylsilane.25
EtOaC
37% aq H2 CO,\~ f~ N  MeaSH (1 2 equiv).
i ^ n \  MeCN, 40 ‘C NaBKjCN,
4 5  Cl 60 (79%) Ac0H’ MeCN 61 (82%)
W
Cl
KOH (4 equiv), \ — LiAIH4  (2 equiv),
MeOH, reflux ^  ether, reflux
62 (40%) 51 83 (13%)
(5)
Conversion of the carbamate 51 into the corresponding methylated hydrazine 63 took place in a rather 
poor yield. An alternative route that provided the N-methyl compound is the reductive methylation of the free 
hydrazine 60, in which the intermediate iminium ion was reduced with sodium cyanoborohydride leading to the 
desired compound 61 in good yield.26
Synthesis of some azatropanone derivatives
In order to convert the cyclization product 53 into azacocaine derivatives 3 two major conversions were 
to be carried out. The methyl carbamate had to be converted into a methyl function and the dioxenone part had to 
be deprotected and reduced. It would be advantageous to perform a catalytic hydrogenation of the dioxenone at 
this stage, as it would immediately give the desired cw-relationship between the two substituents. Various 
catalysts were tried at different pressures of hydrogen gas, but the double bond could not be reduced This 
might be a result of the very hindered nature of this double bond. At the bottom-side, it is shielded by the
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ethylene bridge with the ¿¿m-dimethyi function and at the top-side the carbamate hinders the approach of a 
catalyst If 53 was treated with sodium/ammonia27 the double bond remained unaffected, but instead the NN 
bond was cleaved to give the bicyclic system 68 as a single product in poor yield (eq 6).
Me02C * \
Na (4 equiv),
■ n,—
NH|, -78 'C
H
" " W -
MeOjC
(6)
64(16%)
There are several methods to convert a methyl carbamate into the corresponding tf-methyl compound. 
Direct conversion of 53 into the desired product 66 (see also eq 5) by reduction with lithium aluminum hydride 
led to decomposition of the dioxenone part A useful result was obtained if the carbamate 53 was first cleaved 
with iodotrimethylsilane to give the free hydrazine 65 (Scheme H).2  ^Conversion into the N-methyl compound 
with methyl iodide or dimethyl sulfate did not give satisfactory results. Therefore, a reductive raethylation was 
carried out,26 using 37% aqueous formaldehyde in acetonitrile to give the intermediate iminium ion which was 
further reduced with sodium cyanoborohydride to the methylated compound 66.
Scheme II 
M eO£
M6 3 SII (1.2 equiv),
.... .... .... ..... .... .... .... ..... .... .... ..... .... .... .... ....■ ■ ■ ■ ■ ■ I — H ^
MeCN, 40 ‘C
1 ) 37% aq H2CO (5 equiv), 
NaBH3CN (1 . 6  equiv)
■—  .................. ...............................
2 ) AcOH
CH3 0H ( 1 0  equiv).
. .................................................................. ■■■■■■<
xylenes, 170 *C, 
sealed tube, 1 0  min
PhCOCl (1 . 2  equiv), N
Me
6 6  (90%)
Me02C
67
EtaN (1.05 equiv),
CH2 CI2 COjMe OBz
60(70%)
Efforts to reduce the double bond of the dioxenone at this stage by using a catalytic hydrogenation also 
failed. On the other hand, ring opening of the dioxenone proceeded smoothly and was proven to give the best 
result if the product 66 was heated in a sealed tube for 10 min at 170 *C in xylenes in the presence of an excess 
of methanol (Scheme II). The crude p-ketoester 67 was obtained in a quantitative yield but could not be easily 
purified. Despite the clear *H NMR spectrum of the crude product, flash chromatography led to a very low 
yield. Therefore, crude 67 was treated with benzoyl chloride to afford the azatropane derivative 68 in a 
reasonable overall yield Unfortunately, this product could not be reduced to the desired cocaine derivative. The 
crude P-ketoester 67 was also reduced in the presence of an excess of sodium borohydride at 0 ’C to give the 
ecgonine analog 69 (eq 7). In accordance with the outcome of a similar reduction of 2-(carbomethoxy)- 
tropanone at -30 *C carried out by Carroll et a/.,2* only one isomer was obtained in which both substituents 
occupy the endo-position (allopseudo). They also reported that reduction at 0 *C gave a mixture of the pseudo- 
and the allopseudoisomer. The high stereoselectivity of the reduction of 67 is probably a result of the presence 
of the e/wfo-methyl substituent, which shields the bottom side of the molecule, thus preventing an e/ido-attack.
A novel route to the 1-azatropane skeleton 10035
NaBH4 (10 equlv), 
MeOH. 0-5 *C
(7)
MflQjC Q| |
67 60 (73%)
The stereochemistry of 69 was proven by using NMR NOE-difference techniques. Irradiation of the 
proton adjacent to the hydroxy function (H3) showed an enhancement of the signals of all of the H2 and H4 
protons, thus confirming its equatorial position. Irradiation of the hydroxyl proton showed a slight enhancement 
of the signal of the H2gq proton, but not of the H4 proton, indicating its axial position. The assigned 
stereochemistry of 69 was confirmed by comparison of the coupling constants of H3 and H4 with the 
corresponding data of allopseudococaine28 (in 69: H3: t ,3/  = 4.9 Hz; H4: br t ,3ƒ = 4 Hz; in allopseudococaine: 
H3: dt, 3/=  1.1, 4,8 Hz; H4: dd, 3.1, 4.8 Hz).
Attempts to convert this allopseudoecgonine derivative 69 into the benzoyl ester according to literature 
procedures were not successful.29 A possible explanation might be that the reactivity of the hydroxy function is 
strongly decreased as a result of the presence of the endo-methyl group. Present work in our group is aimed at 
achieving the methodology described here by using 3-pyrazolidinones lacking the geminal methyl groups, so as 
to produce 1-azatropanes with more resemblance to natural products.
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EXPERIMENTAL
Genera! inform ation. All reactions were earned out under an inert atmosphere of dry nitrogen, unless otherwise described 
Standard synnge techniques were applied for transfer of Lewis acids and dry solvents. Infrared (IR) spectra were obtained from CHO3 
solutions, unless indicated otherwise, using a Perkm-Elmcr 298 or Perkin-Elmer 1310 spectrophotometer and wavelenghts (v) are 
reported in cm~l. Proton nuclear magnetic resonance (*H NMR) spcctra were determined in CDCI3 (unless indicated otherwise) 
using a JEOL PMX 60 (60 MHz), a Bruker AC 200 (200 MHz), a Bruker WM 250 (250 MHz) or a Bruker AMX 300 (300 MHz) 
spectrometer. The latter three machines were also used for * 3C NMR (APT) spectra (50, 63 and 75 MHz respectively) in CDCI3 
(unless indicated otherwise). Chemical shifts (5) arc given tn ppm down field from tetramethylsilane. Mass spectra and accurate mass 
measurements were carried out using a Van an MAT 711 or a VO Micromass ZAB-2HF instrument. Elemental analyses were 
performed by Domis u. Kolbc Mikroanalyusches Laboratorium, MUlheim a.d. Ruhr, Germany. R j  values were obtained by using 
ihin-layer chromatography (TLC) on silica gel-coated plasuc sheets (Merck silica gel 60 F254) with the indicated solvent (mixture). 
Chromatographic purification refers to flash chromatography (fc)30 using the same solvent as for TLC and Merck silica gel 60 (230- 
400 mesh) or Janssen Chimica silica gel (0 030-0.075 mm). Melting and boiling points are uncorrected. QfyCl^ was distilled from 
P2O5 and stored over MS 4A under an atmosphere of dry nitrogen. TiC^ and SnCl4 were distilled and stored under a dry nitrogen 
atmosphere as a solution in CH2CI2 . BF^OE^ was disullcd and stored under a dry nitrogen atmosphere. Dry THF and EtjO were 
distilled from sodium benzophenone ketyl prior to use
l-Benzyl-3-pyrazoIidinone-2~carboxylic acid methyl ester (10). A solution of l-benzyl-3-pyrazolidinonel0c (500 mg, 
2.84 mmol) in THF (5 mL) was deprotonated with LDA (prepared from diisopropylamine (0.44 mL, 3.13 mmol) and Ji-butyllithium 
(2 0 mL of a 1.6 M solution in hexane, 3.2 mmol) in THF (10 mL) at 0 *C) at -78 *C and treated at that temperature with a 
solution of McOjCCN (483 mg, 5.68 mmol) m THF (5 mL). The mixture was stirred at *78 *C for 1 h, allowed to warm to it, 
poured into water (50 mL) and extracted with CH2Cl2 (3 x 50 mL). The combined organic layers were dried (MgSCty, filtered, 
conccntratcd in vacuo and chromatngraphcd (ethyl acetaUVhcxane M ) to give 10 (263 mg, 1.12 mmol, 40%) as a colorless oil,Rj-
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0.30. IR v 1780,1735* 1430,1210,690; l H NMR (200 MHz) 5 2.56 (t, J  « 7.5 Hz, 2 H, CHj), 3.32 (t, 7.6 Hz, 2 H, NCH2),
3.90 ( s, 3 H, C 02CH3), 4.04 (s, 2 H, CH2Ph), 7.36 (s, 5 H, ArH).
l-Benzy]*l‘(3-hydroxypropyl)-2-hydrazlnecarboxylic add methyl ester (11), A solution of 10 (44 mg, 0.19 mmol) 
in HiOH (2 mL) was treated with NaBH4  (22 mg, 0.58 mmol) at -78 *C and every 10 mm with one drop of a 2 M ^SO^j/EtOH 
solution. After 1 h (the reaction was monitored with TLC), the mixture was acidified to pH * 3 at -78 *C, allowed to warm to it, 
poured into aq said NaHCOj (20 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic layers were dried (MgSCfy), 
filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:1) to give 11 (36.5 mg, 0.15 mmol, 80%) as a colorless 
oil, R f  0.20. IR v 3440, 3340,1720,1490,1450,1230,690; NMR (200 MHz) S (1.75 (quintet,/ »  5.5 Hz, 2 H, O ty , 2.87 
(br s, 2 H, NCH2), 3.64 (8,3  H, C02CH3), 3.74 (t, J  * 5.3 Hz, 2 H, CHjOH), 3.93 (s. 2 H, CHjPh), 5.72 (br s, 1 H, NH); 13C 
NMR (50 MHz) S 28.9 (CHj), 52.1 (COjCTty, 55.3 (NCH2), 62.0 (CHjPh), 127.5, 128.3, 129.2 (ArH), 135.7 (AiC), 157.0 
(C(0>).
General procedure for the alkylatioa reactions. Tike halide (1.1 equiv), K2CO3 (1.5 eqvuv) and a catalytic amount of UI 
were added to a solution of 3-pyrazolidinone 8 in 2-butanone. The solution was heated at reflux temperature for 18 h, concentrated 
in vacuo, taken up in water and extracted with CH2Cl2  (3 x). The combined organic layers were dried (MgSO )^, filtered and 
concentrated in vacuo. The residue was chromatographed to afford the pure alkylation product.
Method A for the methoxycarbonylation, To a suspension of NaH (obtained from a 55% dispersion in oil by washing with 
dry pentane) in THF was added dropwise a solution of the hydrazide in THF. After being stinted at rt for 30 min, the resulting clear 
solution was cooled to 0 ‘C and a soluuon of MeC^CCl in THF was added. Stirring was maintained at 0 ‘C for 30 min and for 2 h 
at it  The reacuon mixture was concentrated in vacuo and the residue was taken up in water and extracted with CH2Cl2 (3 x ). The 
combined organic layers were dried (MgSO )^, filtered, concentrated in vacuo and purified by fc to afford the pure product
Method B for the ethoxycarbonylation. See procedure A with Et02CCl instead of Me02CCl.
Method C for the ethoxycarbonylation. To a solution of the hydrazide in CH2CI2  were added EtgN (l.l equiv), diethyl 
dicarbonate (2.1 equiv) and a solution of DMAP (1.1 equiv) in C ^ C l^  The light yellow solution was stirred at it for 18 h, 
concentrated in vacuo and purified by fc.
Method D for the m ethoxycarbonylation. To a solution of LDA (prepared from diisopropylamme (1.1 equiv) and n~ 
butyllithium (1.1 equiv) at 0 *Q in THF was added at -78 *C a solution of the hydrazide (1 equiv) in THF. After being stirred at -78 
*C for 1 h, MeC^CCN dissolved in THF, was added and the mixture was allowed to warm to rt. After being stirred for 30 mm, the 
mixture was poured into an ice/water mixture and extracted with ether (3 x). The combined organic layers were dned (MgSO )^, 
filtered and concentrated in vacuo. The pure product was obtained after fc.
General procedure for the reduction reactions with NaBH^. A solution of the funcdonalized pyrazolidinone in ethanol 
was cooled to -20 *C and NaBH4 (6 equiv) was added in one portion. The solution was stirred at -20 'C while each 10 min 1 drop of 
a 2 M solution of sulfuric acid in ethanol was added to the mixture. The reaction was monitored by TLC. After complete reduction 
(2-3 h), the solution was cooled to *78 *C and acidified to pH * 3 with a 2 M H2SO /^EtOH solution. After being stirred at it for 4-5 
h, the reaction mixture was poured into aq satd NaHCO  ^ and extracted with CH2Cl2 (3 x). The combined organic layers were 
washed with water, dried (K2 CO3), filtered and concentrated in vacuo. The residue was chromatographed to yield the pure 
pyrazohdine.
General procedure for the cycllzation reactions with TiClj« To a 0.1 M soluuon of the hydrazide in CH2C12 was added 
T1CI4 (2 equiv, as a soluuon of T1CI4 m CH2CI2) at -78 *C by a syringe. The mixture was stirred at -78 'C for 15 mm and for 5-18 
h at rL The reacuon mixture was poured into cold aq satd NaHCOj and the resulung suspension was filtered over Celite and extracted 
with CH2C12  (3 x). The combined organic layers were dried (MgSC^), filtered and concentrated in vacuo. Purification of the residue
by fc afforded the pure cyclization produces).
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l~Benzyl*5»5~dimethyI-3-pyrazolidinone (12). According to the general procedure, 3-pyrazolidinofve 8 (3.02 g,26.3 mmol) 
was alkylated by using benzyl chlonde (3.03 mL, 26.3 mmol), K2CO3 (4.00 g, 29.3 mmol) and Lil in 2-butanone (130 mL). 
Work-up and fc (ethyl acetate) lfforded 12 (430 g, 22.1 mmol, 80%) as white needles, mp 107.5-108,5 'C (hexane), R j 0.42. IR v 
3430,3400,1685; XH NMR (200 MHz) S 1.35 (s, 6 H, MejC), 2.39 (*, 2 H, CCHj), 3.77 («, 2 H, NCHj), 6.77 (br «, 1 H. NH).
7.31 (s, 5 H, ArH); Anal. Calcd. for C ^ H ^ O ’ C, 70.56; H, 7.90; N, 13.71. Found: C, 70.52; H, 7.92; N, 13.68.
l-Benzyl*5,5-dim ethyl-3-pyrazolidlnoue-2-carboxyllc acid ethyl ester (13) via the method B. 12 (2.03 g, 10.0 
mmol) was treated with NaH (550 mg, 12.7 mmol) and EtOjCCl (2.86 mL, 30 mmol), while all compounds were dissolved in 
THF (30 mL). Work-up and fc (ethyl acetateyihexane 2:1) afforded 13 (1.64 g, 5.94 mmol, 59%) as white crystals, mp 89-92 *C, Rj- 
0.54 and l-benzyl-5,5-dim ethyl-2-Kethoxycarbonyl)oxy]-2-pyrazotine (17) (1.07 g, 3.40 mmol, 39%) as a colorless 
oil, R f  0.92.13: IR v 1780,1740; ]H NMR (200 MHz) 8  1.17 (t, J -  7.1 Hz, 3 H, CH2C«3), 1.28 (s, 6  H, MejC), 2.57 (s. 2
H, CCH2), 4.03 (s, 2 H, NCHj), 4.08 (q. 7.1 Hz, 2 H, CfljCHj), 7.25-7.45 (m. 5 H. ArH). 17; IR v 1760, 1635; *H NMR 
(200 MHz) S 1.33 (t, /  -  7.1 Hz, 3 H, CHjC/fj), 1.34 (s, 6  H, M^C), 2.81 (s, 2 H, CCHj), 3.96 (s. 2 H, NCHj), 4.25 (q, 2 H, 
CH2CH3), 7 15-7.45 (m, 5 H, ArH)
l-Benzyl-5,5-dim ethyl-3-pyrazoUdinone-2«carboxylic acid ethyl ester (13) via method C. A solution of 24 
(2 00 g, 9.80 mmol) in CH2CI2 (40 mL) was treated with EtjN (147 mL, 10.9 mmol), diethyl dicarbonate (2.9 mL, 19.6 mmol) 
and a solution of DMAP (1.20 g, 9.80 mmol) in CH2CI2 (4 mL). After being stirred for 66 h, the solution was concentrated in 
vacuo and purified by fc (ethyl acetate/hexane 2:1) to yield 41 (1 36 g, 4.90 mmol, 81% (after correction)) as white crystals.
] -Benzyl-5,5»dimet)tyl-3-etlioxy-2»pyrazoUdinecarboxyUc acid ethyl ester (14). Following the general procedure, 
13 (2.00 g, 7.24 mmol) was reduced with NaBH  ^ (1.64 g, 43.4 mmol) in EtOH (100 mL), Woik-up and fc (ethyl acetate/hexane 
1-4) afforded 14 (2.02 g, 6.53 mmol, 90%) as a colorless oil, Ay 0.43. IR v 1680; l H NMR (200 MHz) 8  0.97 (t. J  -  7.0 Hz, 3 H, 
OCH2C «3), 1.01 (s, 3 H, Me), 1.19 (t. J  » 7 1 Hz, 3 H, CC^CH^Wj), 1.36 (s. 3 H. Me), 2.21 (dd, J  -  5.2,13.4 Hz. 1 H, 
CHCHH), 2 32 (dd, J  -  7.1,13.4 Hz, 1 H, CHCHW), 3.59 (q. 7.1 Hz, 2 H. OCff2CH3), 3.89 ( d , / -  11.7 Hz. NCHH), 3.92 (q. 
y - 7.0 Hz,2 H,C0 2 C//2CH3) ,4  08(d ,7>  11.7Hz, 1 H, NCHH), 5.56 (dd, J  *  5.3,7.0 Hz, OCH), 7.15-7.45 (m, 5 H, ArH).
3,4»Benzo~lf8-diaza-7,7-dim ethyIbicyclo[3,2.I]octane-8-carboxyllc acid ethyl ester (15). According to the
general procedure, a solution of 14 (1.04 g, 3.4 mmol) in CH2CI2  (34 mL) was treated with TiC^ (5.7 mL of a 1.2 M solution in 
CH2CI2 , 6 8 mmol). After being stirred at rt for 18 h, the reaction mixture was worked-up and the residue was chromatographed 
(ethyl acetate, then ethyl acctatc/hexanc 1*2) to afford 15 (508 mg, 1.95 mmol, 62% (after correction)) as a colorless oil, R f 0.28. 
IR v 1690; *H NMR (200 MHz) S (some signals appear as rotamers) 1.17-1.30 (m, 9 H, 3 x Me), 1.89 (d, /  * 11.8 Hz, 1 H, 
H6endo)’ 2 -23 (dd>J ■ 7*°> n *9 H z>1 H> H6exo>* 4*054.25 (m, 3 H, H2 and CW2CH3), 4.46 (d, 7-17.2 Hz, 1 H, H2), 5.02,5.16 
(d, J  = 6.0 Hz, 1 H, H5), 694-7.15 (m, 4 H, 4 x ArH); *H NMR (250 MHz, CgDg, 65 *C) S 0.97 (s, 3 H, Me), 1.06 ( t , /  = 7.1 
Hz, 3 H, CH2Ctf3), 1.19 (s, 3 H, Me), 1 65 (d, J -  11.8 Hz, 1 H, H6endo), 2.06 (dd, J  -  7.0,11.8 Hz, 1 H, H e ^ ,  3.88 (d, J -
17.6 Hz, 1 H. H2), 4.09 (q, /  * 7.1 Hz, 2 H, CW2CH3), 4.48 (d, J  -  17.6 Hz. 1 H. H2), 5.16 (d. J  -  6.7 Hz. 1 H, H5), 6.60-7.00 
(m, 4 H, 4 x ArH); NMR (50 MHz) S (some signals appear as rotamers) 14,5 (CH2 CH3), 25.4 (Me), 31.9 (Me), 50.9, 51.3 
(C6), 52 7 (C2), 56.7, 57 2 (C5), 61.2,61.5 (CH2CH3), 66.0,66.5 (C7), 124.1,125.4,126.2,127.1 (ArH), 131.0,140.0 (ArC), 
154.0,154 5 (C(0)); MS (El, 70 eV) m h  (relative mlensily) 260 (M+, 81), 245 (11), 204 (62), 187 (37), 159 (370,131 (100), 117 
(72), 91 (36), 77(17); HRMScalcd fo r C ^ tt^ N ^  260.1525, found 260.1529.
3,4-B cnzo-l,8.di«za-7,7-dIm ethylbicyclo[3.2.1]octane (IS). A soluuon of 15 (187 mg, 0.72 mmol) and KOH (160 
mg, 2.88 mmol) in MeOH (7 mL) was heated at reflux temperature for 90 h. The resulting mixture was poured into aq satd NH4 CI 
(25 mL) and extracted with CH2CI2 (3 x 25 mL). The combined organic layers were dried (MgSC^, filtered and concentrated in 
vacuo The residue was chromatographed (acetone) to yield 16 (109 mg, 0.58 mmol, 81%) as a yellow oil, Rj- 0.13. IR v 3390, 
3060; 'H NMR (250 MHz) 8  1.25 (s, 3 H, Me), 1.27 (s, 3 H, Me), 1.95-2.15 (m. 2  H, 2 x H6). 3.90 (br s, 1 H. NH), 4.07 (d. / »
17.3 Hz, 1 H, H2), 4.17 (d, ƒ = 6.0 Hz, 1 H, H5), 4.45 (d, J  =* 17.3 Hz. 1 H. H2). 6.85-7.15 (m, 4 H, ArH); 13C NMR (50 MHz) 
8 26.1 (Me), 32.7 (Me), 53.1,53.3 (C2 and C6), 65.6 (C7). 124.4,125.4,125.8,126.9 (ArH), 132.1,141.7 (AiC); MS (El, 70 
eV) mlz (relative intensity) 188 (M+, 64), 173 (23), 145 (8), 132 (66), 131 (100), 117 (36), 104 (8), 91 (8), 77 (9), 32 (48). 31
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(64); HRMS calcd for C12H16N2 *88.1313, found 188.1320.
5.5-Dim ethyM -(2-propenyl)-3-pyrazolidinom e (18). According to the general procedure, 3-pyrazolidinone 8 (2.0 g, 17,5 
mmol) was alkylated with allyl bromide (1.51 mL, 17*5 mmol), K2CO3 (2.67 g, 19.3 mmol) and Lil in 2-butanone (80 raL). 
Work-up and fc (ethyl acetate) afforded 18 (1.71 g, 11.5 mmol, 6 6 %) as a white solid, mp 40-42 *C, fly 0.19. IR v 3340, 3400, 
3080,1675; l H NMR (200 MHz) 5 1.22 (s, 6  H, MC2C), 2.28 (s, 2 H, CCHj). 3.22 (d, J  « 6.4 Hz, 2 H, NCHj), 5.15 (dd, J  « 
1.8, 8.1 Hz, 1 H, *CtfH), 5.23 (d, J  * 2.8 Hz, 1 H, *CHfl), 5.65-5.90 (m, 1 H, -CH), 8.27 (br s, 1 H, NH).
5.5-Dim ethyl-l-(2-m ethyI-2-propeiiyl)-3-pyrazoIidinon« (19). 3-pyrazolidinone 8 (1.00 g, 8.80 mmol) was alkylated 
(according to the general procedure) with 3-chloro-2-methyI-l-propene (0.91 mL, 9,21 mmol)» K2CO3 (1.27 g, 9.20 mmol) and Lil 
in 2-butanone (50 mL). After work-up and fc (ethyl acetate), 19 (1.29 g, 7.69 mmol, 88%) was obtained as a white solid, mp 97.5-
98.5 *C (ether), tfy0.45. IR v 3430,3400,3080,1680; *H NMR (200 MHz) 8  1.25 (s, 6  H, McjC), 1.75 (s, 3 H, Me), 2.34 (s. 2
H, CCftj), 3.12 (s, 2 H, NCHj), 4.92 (m, 2 H, -CHj), 7.24 (br s. 1 H, NH); Anal. Calcd. for C j H ^ O :  C, 64.25; H, 9.59; N, 
16.65. Found: C, 64.27; H, 9.57; N, 16.56.
l-(2-Butenyl)-5,5-dim ethyl-3»pyrazolidhioiie (20). Following the general procedure, 3-pyrazolidinone 8 (3.02 g, 26.3 
mmol) was alkylated by using 4~bromo-2*butene ((E)/(Z) 3.3:1) (2.8 mL, 27.6 mmol), K2CO3 (3.82 g, 27.6 mmol) and Lil in 2- 
butanone (100 mL). After work-up and fc (ethyl acetate), 20 (2.71 g, 16.0 mmol, 62%) was obtained as white crystals, mp 66.5-68 
•c, R f 0.20, (£)/(Z) 3.3:1. IR v 3430,3190,1689; (Eyisomer. !H NMR (200 MHz) 8  1.29 (s. 6  H, MejC), 1.69 (dt, J -  6.3,1.0 
Hz, 3 H, Me), 2.35 (s, 2 H, CCHj), 3.21 (d, 7 «6.5 Hz, 2 H, NCH2), 5.35-5.55 (m, 1 H, CHjCff*), 5.60-5.80 (dq. / =  15,6.3 
Hz, CH3CW), 7.60 (br s. 1 H. NH). (Z)-isomei: *H NMR (200 MHz) 8 1.32 (s, 6  H, MejQ. 1.69 (dt, J  « 1.0,6.3 Hz. 3 H, Me), 
2.38 (s. 2 H, CCHj), 3.33 (d. J  » 6.9 Hz, 2 H, NCHj), 5.35-5.55 (m, 1 H, CH2Cff-). 5.60-5.80 (m, 1 H, C//CH3). 7.60 (br s, 1
H, NH).
5l5-Dimethyl-l-(3*methyl-2*butenyI)-3-pyrazoUdlBOne (21). Following the general procedure, 3-pyrazohdinone 8 
(7.61 g, 67.0 mmol) was alkylated by using 4-bromo-2-methyl«2-butene (10.5 g, 70.5 mmol), K2CO3 (13.9 g, 0.10 mol) and Lil 
in 2-butanone (400 mL). After work-up and fc (ethyl acetate), 21 (9.75 g, 53.6 mmol, 80%) was obtained as white needles, mp
96.5-97 *C (CH2Ciyether 1:10),R t 0.30. IR v 3430,1685; JHNMR (200 MHz),81.30 (s, 6 H, Me2C), 1.74 (s. 3 H, Me),2.36 
(s, 2 H, CCH2), 3.30 (d, /  »  7.1 Hz, 2 H, NCH2), 5.20 (U, J  -  U ,  7.1 Hz, ®CH), 6.90 (br s, 1 H, NH).
5|5-Dim ethyl-l-(2*propynyI)-3-pyrazoIidinone (22). Fallowing the general procedure, 3-pyrazohdmone 8 (4.02 g, 35.1 
mmol) was alkylated by using 3-bromo-l-propyne (4.11 mL, 36.9 mmol), K2C0 3 (5.11 g, 36.9 mmol) and Lil in 2-butanone (150 
mL). Work-up and fc (ethyl **UUe/acetone 1;1) afforded 22 (2.H g, 13.9 mmol, 40%) as yellow crystals, mp 100-105 *C, Rf 0.54 
and5,5-din)ethyl-l,2-dl(2-propynyl)-3-pyrazolldinone (22a) (2.01 g, 10.5 mmol, 30%) as a dark oil, Rf 0,89. Data for 
22: IR v 3430,3300,2250,1690; *H NMR (200 MHz) 8  1.32 (s, 6 H, Me2C), 2.27 (t, J  -  2.4 Hz, 1 H, C-CH), 2.44 (», 2 H, 
CCH2), 3.52 (d, J  -  2.4 Hz, 2 H, NCHj), 8.07 (br s, 1 H, NH). Data for 22a: IR v 3300,2250,1690; *H NMR (200 MHz) 8
I.29 (s, 6 H, Me2C), 2.11 (s. 2 H, CCH2), 2.25 (t, J  «  2.3 Hz, 2 H. 2 x C«CH), 3.45-3.75 (m, 4 H, 2 x  NCHj).
5 .5-D im ethyI-l-(2-((trim ethylslIy])m ethyl]-2-propenyl}-3-pyrazoH d[B on e (23). According to the general 
procedure, 3-pyrazolidinone 8 (2.50 g, 21.5 mmol) was alkylated upon use of 2-chloromethyl-3-(trimethylsiIyl)-l-propene (2.90 g,
22.8 mmol), K2CO3 (2.73 g, 19.7 mmol) and Ld in 2-butanone (70 mL). Work-up and fc (ethyl acetate) afforded 23 (3.61 g, 14.8 
mmol, 83%) as white crystals, mp 59-61 'C (ether), R f  0.60. IR v 3440.3400,3080.1690,1250,850; *H NMR (200 MHz) 8 0.0 
(s. 9 H, Me3Si), 1.26 (s, 6  H, MejC), 1.61 (d, J  » 0.7 Hz, 2 H, CH2Si), 2.34 (s, 2 H, CCH2), 3.08 (s, 2 H. NCH2), 4.72 (d, J  = 
0.6 Hz, 1 H. -C/ffl), 4.85 (d, /  * 1.9 Hz. 1 H, -CHW), 6.83 (br s, 1 H. NH).
5 » 5 -D im « th y l-l-[4 -(tr lm eth y lsily l)-2 -b u ty n y l]-3 -p y ra zo lid in o iie  (24), Following the general procedure, 3- 
pyrazolidmone 8 (2,60 g, 22.8 mmol) was alkylated with 4-iodo-l-(trimethylsilyl)-2-butyne20,21 (6.00 g, 23.9 mmol) and K2C03 
(3.30 g, 23.9 mmol) in 2 -butanone (130 mL). After work-up and fc (ethyl acetate), 24 (3,70 g, 15.4 mmol, 68  %) was obtained as 
yellowish crystals, mp 81.5-83.5 *C (ether), R f  0.45. IR v 3420, 3200,2220,1690,1250,850; ^H NMR (200 MHz) & 0.09 (s, 9
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H, Me3Si), 1.33 (s, 6  H, MejC), 1.46 (1 ,7«  2.4 Hz, 2 H, CH2Si), 2.42 (s, 2 H, C O ty, 3.52 (t, ƒ « 2.4 Hz, 2 H, NCH2). 7.70 
(br s, 1 H, NH).
5.5-Diiiiethyl-l-[(3,3-dim etliyl«5*oxo*2,4-diox»6*eiijl)m ethyl]-3-pyrazondiBone (25). According to the general 
procedure, 3-pyrazoiidinone 8 (3.55 g, 31.1 mmol) was alkylated wilh dioxenone22 (5.50 g, 31,2 mmol), K2CO3 (4.7 g, 34 mmol) 
and a catalytic amount of Lil in acetone (130 mL). After being stirred at 45 *C for 48 b, (he mixture was worked'Up and purified by 
fc (ethyl acetate) to afford 25 (4.79 g, 18.9 mmol, 61%) as orange crystals, mp 112.5-113 *C (pentane/ether/CHjC^ 10:10:1), Ry 
0.28(ethylacetate).IRv 3420,1720,1635,1385,1370,1270,1010; 'hN M R (200MHz) 8  1.30(s,6H,Me2CC), 1.71 (s ,6 H, 
MejCO), 2.36 (s , 2 H, CH2), 3.40 (s, 2 H, NCHj), 5.52 (s , 1 H, =CH), 7.70 (br J, 1 H, NH); 13C NMR (50 MHz) 8 24.9 (4 x 
Me), 42.7 (CH2), 54.1 (NCH^, 63.0 (NQ, 94.6 (=CH), 107.0 (OCO), 160.6, 167.3, 174.9 (2 x C(0) and =C); MS (El, 70 eV) 
w /i (relative intensity) 196 (M+-58.100), 127 (100), 83 (62), 43 (74).
5.5-Dim ethyl-3-[(m ethoxycarbonyl)oxy]*l»(2-propenyl)-2*pyrazolioe (2 <). According to method A, 18 (2.00 g,
13.0 mmol) was treated with NaH (680 mg, 15.6 mmol) and MeC^CCI (3.0 mL, 39 mmol), all compounds dissolved in THF (20 
mL). Work-up and fc (ethyl acctatc/hcxane 1:1) afforded 26 (920 mg, 4.3 mmol, 33%) as a yellow oil, R j  0.74. IR v 3080,1760, 
1630; 'h  NMR (200 MHz) 8 1.26 (s. 6  H, M e ^ , 2.73 (s, 2 H, C O ty, 3.40 (dd, J  »  1.2.6.1 Hz, 2 H, NCHj), 3.81 (s. 3 H, 
COjCHj). 5.11 (dd,7 = 1 2 ,10.7 Hz. 1 H. =CHH), 5.22 (dd. J  = 1.2,1 1 2  Hz, 1 H. «CHH), 5.85-6.05 (m, 1 H. =CH).
5.5-Dimethyl>l-(2~propenyI)-3»pyrazoHdinone-2*carbaxylic acid ethyl ester (27). According to method C, a 
soluuon of 18 (12 6 g, 82.0 mmol) in CH2CI2  (300 mL) was treated with Et3N (11.6 mL, 86 mmol), diethyl dicarbonate (24.1 
mL, 164 mmol) and a solution of DMAP (10.0 g, 82.0 mmol) m CH2Cl2  (30 mL). After concentration in vacuo and purification 
by fc (ethyl acetate), 27 (11.5 gr 50.9 mmol, 82% (after correction)) was obtained as a colorless oil, R j  0.64. IR v 3080,1780, 
1730; !H NMR (200 MHz) 8 1.23 (s. 6  H, M e^ ), 1.24 (t, 7 -  7.1 Hz, 3 H, CH2CHj), 2.43 (s, 2  H, C O ty, 3.46 (d, 7 -  6.9 Hz.
2 H, NCH2), 4.22 (q, 7= 7.1  Hz, 2  H, Ctf2CH3), 5.05-5.13 (m, 2 H, -CH2), 5.75-5.90 (m, 1 H, -CH).
5.5-D im ethyI-l-(2-m ethyl-2-propenyi)-3-pyrazoIidinone-2-carboxyIic acid methyl ester (28). According to 
method A, 19 (500 mg, 2.98 mmol) was reacted with NaH (79 mg, 3.28 mmol) and MeO^CCl (0.69 mL, 8.94 mmol) in THF (5 
mL), Work-up and fc (ethyl acetate/hexane 1:1) afforded 28 (497 mg, 2.20 mmol, 74%) as a colorless oil, /?ƒ 0.45. IR v 3090, 
1810, 1760; ’h NMR (200 MHz) 8 1.27 (s, 6  H, Mc2C), 1.84 (s, 3 H, Me), 2.53 (s, 2 H, CCH2), 3.34 (s, 2 H. NCH^, 3.78 (s,
3 H, C02CH3), 4.84,4 8 6  (s, 2 H, s O ty .
l-(2-ButenyI)-5,5-dimethyl-3-[(me1hoxycarbonyI)oxy]-2*pyrazoline (29). Following method A, 20 (2.20 g, 13.1 
mmol) was treated with NaH (630 mg, 14.4 mmol) and MeC^CCl (3.04 mL, 39.3 mmol), all compounds were dissolved in THF 
(30 mL). Work-up and fc (ethyl acctate/foexane 1*2) afforded 29 (1.40 g, 6.21 mmol, 47%) as a colorless oil, (£)/(Z)-ratio 3.3:1, /?ƒ 
0.75. IR v 1760, 1630; (£)-isomen ]H NMR (200 MHz) 8  1.26 (s, 6  H, Me2C), 1.67 (d, 7 -  4.6 Hz, 3 H, Me), 2.74 (s, 2 H, 
CCH2)F 3.33 (dd, 7 = 1.1,3.9 Hz, 2 H, NCH2), 3.82 (s, 3 H, CC^CHj), 5.55-5.70 (m, 2 H, HC-CH); (Z>isomer l H NMR (200 
MHz) 8  1.28 (s, 6  H, Me2C), 1.65 (d,7 «  6.1 Hz, 3 H, Me). 2.75 (s. 2 H, CCH2), 3.45 (dd. 7 « 1.1,3.9 Hz, 2 H, NCHj), 3.82 (s,
3 H. C02CH3). 5.55-5.70 (m, 2 H, HC»CH).
l-(2-Butenyl)-5,5-dlm ethyl-3-pyrazolidlnone-2-carboxyllc acid ethyl ester (30). Following method C, a solution 
of 20 (1.13 g, 6.70 mmol) in CH2Cl2  (25 mL) was treated with Et3N (0.9 mL, 6.7 mmol), diethyl dicarixwiate (1.97 mL, 13.4 
mmol) and a solution of DMAP (0.82 g, 6.7 mmol) m CH2CI2 (5 mL). Concentration in vacuo and fc (ethyl acetate) afforded 30 
(1.03 g, 4.3 mmol, 64%) as a yellowish oil, /?ƒ 0.76, (£)/(Z)-raUo 3.3:1. IR v 1780,1730; (£)-isomen *H NMR (200 MHz) 5
I,26 (s, 6 H, Me2C), 1.30 (t, J  * 7.1 Hz, 3 H, C ^ C /ty , 1.60 (d, J -  4.8 Hz, 3 H, Me), 150 (s, 2  H, CCH2), 3.57 (d, J « 5.4 
Hz, 2 H, NCHj), 4.28 (q, 7 = 7.1 Hz, C/^CHj), 5.40-5.70 (m. 2 H, CH-CH); (Z)-isomer *H NMR (200 MHz) 8 1.27 («, 6  H, 
rvfojC), 1.30 (t, 7 = 7.1 Hz, 3 H, CH2C//3), 1.56 (d, 7 -  9.2 Hz. 3 H, Me), 2.46 (s. 2 H, CCHj), 3.43 (d, 7 «  7.1 Hz, 2 H, NCH- 
2), 4 28 (q, 7 = 7 I Hz, C«2CH3), 5.40-5.70 (m, 2 H, CH-CH).
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5.5-DimethyM-(3-tn<thyl-2-biitc)iyl)-3-pyrazoUdinoiit-2-carboxyllc add methyl ester (31) via method A.
21  (2.02 g, 11.0 mmol) was treated with NaH (380 mg, 15.8 mmol) and MeOjCCl (2.56 mL, 33.0 mmol) in THF (20 mL). 
Woric-up and fc (ethyl acetate/hexane 1:1) afforded 31 (635 mg, 2.65 mmol, 24%) as a light yellow oil, Rj- 0.27 and 5,S- 
dim ethyl[(3-m ethoxycarbonyl)oxy]-l-(3-m ethyl-2-butenjl)-2-pyraxolin< (32) (486 mg, 2.0 mmol, 18%), as a
yellowish oil. 31: IR v 3030, 1780, 1730; JH NMR (250 MHz) 8 1.32 (s, 6  H, MejC), 1.58 (s, 3 H, Me), 1.70 (s, 3 H, Me), 
2.51 (s, 2 H, CCIty, 3.55 (d, J  -  7.6 Hz, 2 H, NCHj), 3.85 (s. 3 H, COjCH^, 5.20-5.35 (m, 1 H, -CH). 32: IR v 3030,1760, 
1630; !H NMR (200 MHz) 8  1.28 (s, 6  H, MejC), 1.65 (s, 3 H, Me), 2.27 (d, J  -  0.9 Hz. 3 H, Me), 2.74 (a, 2 H. CCHj), 3.37 
(d. J  = 6.5 Hz, 2 H, NCH2), 3.83 (s, 3 H, C02CH3), 5.30-5.45 (t, /  = 6.5 Hz, 1 H, -CH).
5.5-Dunethyl-l-(3-methyI*2-butenyl)-3»pyrazoHdinone-2-carboxyIic acid methyl eiter (31) via method D.
21 (25 mg, 0.14 mmol) was alkylated by using LDA (prepared from diisopropylamine (24 mL, 0.17 mmol) and *-butyllithium 
(105 mL, 0.17 mmol)) and MeC^CCN (24 mg, 0.28 mmol), all compounds dissolved in THF (1 mL). After woric-up and fc (ethyl 
acetate/hexane 1:1), 31 (31 mg, 0.13 mmol, 93%) was obtained a» a colorless oil, Rf 0.30.
5.5-Dimethyl-l-(2-propynyl)»3-pyrazoUdinoiie-2-carboxylic add ethyl ester (33). Following method B, 22  (1.06 
g, 7.00 mmol) was treated with NaH (201 mg, 8,36 mmol) and EtO^CCl (2.0 mL, 21 mmol) in THF (50 mL). Work-up and 
purification by fc (ethyl acetale/hexane 1:1) afforded 33 (1.05 g, 4,70 mmol, 67%) as a light yellow oil, R f  0.41. IR v 3300,2105, 
1780,1725; JH NMR (200 MHz) 8 1.34 (t, /  * 7.1 Hz, 3 H, C H ^ffj), 1.34 (s. 6  H, MejC), 2.30 (t, J  -  2.4 Hz, 1 H, C«CH),
2  74 (br s, 2  H, CCH2), 3.81 (d, / -  1.7 Hz, 2  H, NCHj), 4.32 (q, J  « 7.1 Hz, 2 H. Ctf2CH3).
5.5-D im ethyl-l-{2-[(trim ethylsilyl)m ethy]]-2-propenyl}-3-pyrazolid inone*2-carboxyIlc acid ethyl ester 
(34). Following the general procedure C, a solution of 23 (3.50 g, 14,6 mmol) in CH2O 2 (60 mL) was treated with Et3N (2.06 
mL, 15.3 mmol), diethyl dicarbonate (8.6  mL, 58 mmol) and a solution of DMAP (1.78 g, 14.6 mmol) in CH2CI2 (10 mL). 
Concentration in vacuo and purification by fc (ethyl aoetatc/hexane 1:2) afforded 34 (2.11 g, 6.76 mmol, 62% (after correction)) as a 
colorless oil, rty 0.38. IR V 3080,1780,1740,1250, 850; *H NMR (200 MHz) 8 0.0 (s, 9 H, Me3Si), 1.27 (s, 6 H, Me2C), 1.29 
(t, J  -  7.1 Hz, 3 H, CH2CW3), 1.70 (d, J  -  0.5 Hz, 2 H, CH2Si), 2.52 (s, 2 H, CCH^, 3.23 (s, 2 H, NCH2), 4.23 (q, J * 7.1 Hz,
2 H, Ctf2CH3), 4.66 (s, I H. =CWH), 4.83 (t, J=  0,7 Hz, 1 H, «CHH).
5.5-D im ethyl-l-[4-(trim ethylsU yl)-2-butynyI]-3-pyrazolidinone-2-carboxylic acid m ethyl ester (35) via
method A. 24 (412 mg, 1.73 mmol) was treated with NaH (51 mg, 2.1 mmol) and MeC^CCl (0.40 mL, 5.2 mmol) in THF (15 
mL). Work-up and purification by fc (ethyl axtate/hcxane 1:1) afforded 35 (317 mg, 1.07 mmol, 62%) as a colorless oil, Rf 0.60. 
IR v 2250, 1780,1730,1250, 850; 'h  NMR (200 MHz) 8 0.03 (s, 9 H, Me3Si), 1.33 (s, 6 H, Me2C), 1.39 (t, J  -  2.3 Hz, 2 H, 
CH2Si), 2.73 (br s, 2 H, CCH2), 3.79 (br s, 2 H, NCH2), 3.87 (s, 3 H, COjCHj).
5.5-D im ethyM -[4-(trim ethylsnyl)-2-butynyl]-3-pyrazoU dinohe-2-cflrboxylic acid methyl ester (35) via
method D. 24 (130 mg, 0.55 mmol) was alkylated upon use of LDA (prepared from diisopropylamine (84 pL, 0.60 mmol and *- 
butyllithium (380 nL, 0.61 mmol)) and MeC^CCN (94 mg, 1.10 mmol). Work-up and fc (ethyl acetate/hexane 1:1) afforded 35 (87 
mg, 0.29 mmol, 53%) as a colorless oil, Rf 0.60.
5.5-D im ethyl-1-[(3 ,3-dim ethyl-5-oxo*2,4-diox-6-enyl)methyIl*‘3-pyrazolldinone-2-carboxylie acid methyl 
ester (36), To a suspension of NaH (29 mg, 1.2 mmol) in THF (2 mL) was added dropwise at rt a solution o f25 (303 mg, 1.2 
mmol) in THF (4 mL). After being stirred for 15 min, the resulting clear solution was cooled to 0 *C and a solution of MeC^CCN 
(306 mg, 3.6 mmol) in THF (1 mL) was added. The mixture was stirred at 0 *C for 15 min and an additional 2 h at rt and poured 
into aq satd NaCl (20 mL) and extracted with CH2CI2 (3 x 40 mL). The combined organic layers were dried (MgSC^), filtered and 
concentrated in vacuo. The residue was chromatographed (ethyl acetate) to give 36 (255 mg, 0.82 mmol, 68%) as while crystals, mp 
116-117 'C (ethyl acetate/hexane).*,0.52. IR v 1790,1735,1720,1635,1310,1285,1015; 'H NMR (200 MHz) 8 1.28 (s. 6  H. 
Me2 CC), 1.69 (s, 6 H, Me2CO), 2.79 (s, 2 H, CH2), 3.45 (s, 2 H, CH2), 3.86 (s, 3 H, CC^CH^, 5.60 (s, 1 H, -CH); 13C NMR 
(50 MHz) 8 24.8 (2 x Me), 25.3 (2 x Me), 42.9 (CH^, 53.6 (NCHj), 53.8 (CC^Oty, 61.6 (NC), 95.2 (»CH), 106.7 (OCO),
150 4,160.4,167.5,171.7 (3 x C(0) and »Q, MS (El. 70 eV) ml 2 (relative intensity) 312 (M+. 7), 254 (48), 185 (100), 103 (20),
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83 (41), 69 (27), 43 (27); HRMS calcd for C^HjqN ^  312.1321, found 312.1306.
5.5-D i»ethyl-3-ethoxy-l-(2-propenyl)-2-pyrazolidinecarboxylic acid ethyl ester (37). According to the general 
procedure, 27 (10*0 g, 44.2 mmol) was reduced wiih NaBfy (10.0 g, 0.27 mol) in EtOH (500 mL). After work-up and fc (ethyl 
acetateAvexane 1:1), 37 (9.36 g, 26.6 mmol, $3%) was obtained as a light yellow oil, R f 0.50. IR v 3080,1720,1680; NMR 
(200 MHz) 8 0.95 (s, 3 H, Me). 1.08 (t, 7 « 7.1 Hz, 3 H, OCH2C//3), U 9  ( t ,/  « 7.0 Hz, 3 H. COjCHjC/ty, 1.26 (s, 3 H, Me),
2.02 (d d ,/* 4,7,13.5 Hz, 1 H, CHC//H), 2.22 (dd,7 = 6.0,13.5 Hz, 1 H. CHCH/f), 3.30-3.70 (m, 4 H, OC//2CH3 andNCH^, 
4.15 ( q , / -  7.0 Hz, 2 H, C O ^ ^ C H ^ , 5.01 (s, 1 H, *C//H), 5.07 (d, /  « 10,0 Hz, 1 H, =CHW), 5.49 (dd, /  * 5.0,6.0 Hz, 1 H, 
OCH), 5.85-6.10 (m, 1 H,=CH).
5.5-D im ethyl-3-ethoxy-l-(2-m *thyl-2-propeny|)-2-pyraioIidinecarboxync acid methyl ester (38). Following 
the general procedure, 26 (465 mg, 2.06 mmol) was reduced with NaBfy (467 mg, 12.3 mmol) in EtOH (25 mL). After work-up 
and fc (ethyl acetate/hexane 1:1), 38 (397 mg, 1.55 mmol, 75%) was obtained as a colorless oil, R f  0.78. IR v 3070, 1680; *H 
NMR (200 MHz) 5 0.99 (s, 3 H, Me), 1.16 (t, 7 » 7.0 Hz, 3 H, CH2CH3), 1.28 (s, 3 H, Me), 1.85 (s, 3 H, Me), 2.07 (dd, 7 « 4,9, 
13 5 Hz, I H, CHC//H), 2.27 (dd, 7 -  7.3, 13.4 Hz, I H, CHCHƒƒ), 3.38 (s, 2 H, NCH2), 3.59 (q, 7 « 7.0 Hz, 2 H, C//2CH3), 
3 69 (s, 3 H, C 02CH3), 4.82 (s, 2 H, -CH^), 5.55 (dd. /  m 5 0,7,2 Hz, 1 H, OCH).
l-(2-B uteny!)-5*5-dim ethyl-3-ethoxy-2‘>pyra*oHdinecarboxyIic acid ethyl ester (39), Following the general
procedure, 30 (502 mg, 2 1 mmol) was reduced with NaBfy (473 mg, 12.6 mmol) in BtOH (25 mL). Work-up and fc (ethyl acetate) 
afforded 39 (404 mg, 1.5 mmol, 71%) as a colorless oil, (E)/(Z)-ratio 3.3:1, Rj0.70. IR v 1690; *H NMR (200 MHz) 8 (mixture)
0 98 (s, 3 H, Me), 1.14 (t, J  = 7.0 Hz, 3 H, OCH2C//3), 1.24 (t, 7  « 7.0 Hz, 3 H, C02CH2C//3), 1.29 (s, 3 H, Me), 1.55 (m, 3
H, CHCW3), 2.07 (dd, 7 » 4 7, 13.5 Hz, 1 H, CHCWH), 2.24 (dd,;  * 7.3,13.4 Hz, I H, CHCHW), 3.30-3.45 (m, 2 H, NCH^,
3 45-3 75 (m, 2 H, OC//2CH3), 4.05-4.40 (m, 2 H, C02C//2CH3), 5.45-5.65 (m, 3 H, CH-CH and OCH).
5.5-Dim ethyl-3-ethoxy-l-(3-m ethyI-2-butenyl)-2-pyrazoIidinecarboxylic acid methyl ester (40), Following the 
general procedure, 31 (634 mg, 2.35 mmol) was reduced with NaBH  ^(620 mg, 16.5 mmol) in EtOH (60 mL). After work-up and fc 
(ethyl acetate/hexane 1 1), 40 (318 mg, 1.18 mmol, 44%) was obtained as a colorless oil, Rf 0.55. IR v 3030,1685; H^ NMR 
(250 MHz) 5 0.96 (s, 3 H, Me), 1.09 (t, /  » 7.0 Hz, 3 H, CH2C//3), 1.28 (s, 3 H, Me), 1.56 (s, 3 H, Me), 1.64 (s, 3 H, Me), 2,06 
(dd, /  * 5.0,13.4 Hz, 1 H, CHC//H), 2.23 (dd, 7 -  7 3,13.4 Hz, 1 H, CHCHW), 3.35-3.40 (m, 1 H, NC//H), 3.45-3.65 (m, 3 H, 
NCHtf and OT2CH3), 3.70 (s, 3 H, C O jO ty, 5.27 (br s, 1 H, =CH), 5.51 (dd, 7 *  5.4,6.8  Hz, 1 H, OCH).
5.5-Dimethyl«3-ethoxy-l-(2-propynyl)-2-pyrazoIidinecarboxyHc acid ethyl ester (41). According to the general 
procedure, 33 (1.00 g, 4.50 mmol) was reduced wiih NaBH  ^ (1 02 g, 27.0 mmol) in EtOH (50 mL). After work-up and fc (ethyl 
acetate/hexane 1:1), 41 (741 mg, 2.92 mmol, 65%) was obtained as a colorless oil, Rf 0 56. IR v 3310, 1690; *H NMR (200 
MHz) 8 0 93 (s, 3 H, Me), 1.07 (t, 7= 7.1 Hz, 3 H, OCH2a / 3), 1.18 (t,7 *  7.1 Hz, 3 H, C02CH2Cff3), 1.22 (s ,3 H, Me), 1.95 
(dd,7 = 4.4,14 2 Hz, 1 H, CHO/H), 2.07 (t, 7 * 2.4 Hz, 1 H, C»CH), 2.20 (dd, 7 « 7.2,13.6 Hz, 1 H, CHCHtf), 3.50-3.70 (m, 2
H, OC//2CH3), 3 61 (dd, 7  * 2.4, 9.3 Hz, 2 H, NCH2), 4.05-4.25 (m, 2 H, C02C//2CH3), 5.50 (dd, 7 *  4.5,7.0 Hz, 1 H, OCH).
5.5-D im ethyl-3-ltydroxy-l-{2-[(triT nethylsU y])m etliyl]-2'propenyl}-2-pyrazolidinecarboxylic acid ethyl 
ester (42). Following the general procedure, 34 (678 mg, 2.17 mmol) was reduced with NaBH  ^ (493 mg, 13.0 mmol) in EtOH 
(25 mL). After being suited for 2 h at -20 'C, the reaction was quenched with cold aq satd NaHC03 (30 mL). After work-up 
according to the general procedure and fc (ethyl acetate/hexane 2.2:1), 42 (653 mg, 2.08 mmol, 96%) was obtained as a white solid, 
mp 66-68 *C (hexane), R f  0.68. IR v 3450,3080,1725, 1660,1240,850; 'h  NMR (200 MHz) 8 0.0 (s, 9 H, Me3Si), 1.05 (s. 3
H, Me), 1 25 (t, J = 7 0 Hz, 3 H. CH2Ctf3), 1.26 (s. 3 H, Me), 1.63 (d, J * 13.6 Hz, 1 H, CtfHSi). 1.84 (d. 1 H, J *  13.6 Hz, 
CHWSi), 2.07 (dd. J m 5.4, 13 3 Hz, 1 H, CHC//H), 2 22 (dd, J = 7.2, 13.2 Hz, 1 H, CHCHH), 3.25 (s. 2 H, NCHj), 4.05-4.20 
(m, 2 H, C//2CH3), 4.62 (s, 1 H, =C«H), 4.80 (s, 1 H, *CHH), 5.71 (t, J  -  5.4 Hz, 1 H. OCH).
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5 .5 -D¡m ethyl-3 -faydroxy-l'(4 ~(trltnethyIsiiyl)-2 -butyayl]'2 -p7 raxoIidÍ9 ecarboxylÍc acid methyl ester (43).
Following the general pnocedure, 35 (315 mg, 1.06 mmol) was reduced with NaBH  ^(241 mg, 6.39 mmol) in EtOH (10 mL), After 
being stirred at -20 *C for 2 h, the reaction was quenched with cold aq satd NaHCX  ^(50 mL) and worked up following the general 
procedure, fc (tthyl acetatetfiexane 3:2) afforded 43 (185 mg, 0.62 mmol, 59%) as a colorless oil, fly 0.52. IR v 3500,2200,1679, 
1250, 850; l H NMR (200 MHz) 8 0.07 (s, 9 H, Me3Si), 1.15 (*, 3 H, Me), 1.35 (s, 3 H, Me), 1.45 (i, J  -  2.3 Hz, 2 H, CH2 Si), 
2.18 (br », 1 H, CHCHH), 241 (dd, J  -  7.3,13.2 Hz, 1 H, CHCHW), 3.45 (br s, 1 H, OH), 3.66 (br s, 2 H, NCH2), 3.79 («, 3 H, 
CO2CH3), 5.71 (br s, 1 H, OCH).
5 .5-Dim ethyl 1-[(3 ,3 -d im e thy I-5-oxo-2,4-dIox-6-eny I) m ethyl]-3-etboxypyraxolid l*e-2-carboxylfc acid  
methyl ester (44). Following the general procedure, 64 (59 mg, 0.19 mmoO was reduced with NaBH  ^ (29 mg( 0.76 mmol) in 
EtOH (2 mL). After work-up and flash chromatography (ethyl acetate/hexane 1:1), 64 (44 mg, 0.13 mmol, 68%) was obtained as 
white crystals, mp 115-116 ‘C (ethyl mcttale/hexane l:l),*y0.38. IR v 1720,1700,1635,1445,1370, 1110. 1060, 1025,900; ]H 
NMR (200 MHz) 8  1.02 (s. 3 H, Me), 1.17 (t, J  « 7.1 Hz, 3 H, CH2 CH $, 1.41 («, 3 H, Me), 1.67 (*, 3 H, Me), 1.69 (s. 3 H. 
Me), 2.05 (dd, J  » 4.7, 13.4 Hz. 1 H, CHCWH), 2.31 (dd, J  *  7.2, 13.6 Hz, 1 H, CHCHfl), 3.50-3.75 (m, 4 H, NCH2  and 
CH2CH3), 3.73 (j , 3 H. COjCH^, 5.55-5.60 (m, 1 H, CHO), 5.60 (s. 1 H, -CH); 13C NMR (50 MHz) 8  14.8 (CHjOty, 23.0 
(Me), 24.4 (Me), 25.1 (Me), 28.1 (Me), 45.2 (CH2), 52.9 (COjCTty, 54.8 (NCHj), 64.1 (OAjCHj), 65.8 (NQ. 90.9 (OCH),
95.3 (=CH), 106.7 (OCO), 154.0, 161.0, 168.0 ( 2 x C(O) and =C); MS (El, 70 eV) mlt (reiaUve intensity) 342 (M+, 15), 284 
(100), 239 (50), 216 (100), 159 (100), 113 (60), 103 (37), 43 (27); HRMS calcd for C16H22N2Q6 342.1791, found 342.1801; 
Anal. Calcd. for CjgH^NjOg: C, 56.12; H, 7.65. Found: C, 55.75; H, 7.68.
rt/-(3S ,5£)»3-C h Ioro-l,8 -d iaza-7 ,7 -d lm eth y lb icyclo [3 .2 .1 ]octan e-8-carb oxyH c acid ethyl ester (45). 
According to the general procedure, 37 (3.00 g, 11.7 mmol) dissolved in CH2CI2 (120 mL) was cyclized with T1Q 4 (19.5 mL of a
1.2 M solution, 23.4 mmol). The mixture was worked-up after being stirred at rt for 18 h and the residue was purified by fc (ethyl 
acetate) to afford 45 (2.72 g, 11.1 mmol, 95%) as a yellow oil, fly 0,76. IR v 1670; JH NMR (200 MHz) 6 (some signals appear 
as rotamers) 1,11,1.16 (s, 3 H, Me), 1.28 (t,7 »  7.0 Hz, 3 H, CH2C//3), 1.41 (s. 3 H. Me), 1.65 (br dt 12.9 Hz, 1 H, H6 cndo), 
2.00-2.25 (m. 3 H, H6 W 0 and 2 x H4), 3.05-335 (m, 1 H, H2), 3.40-3,50 (m, 1 H, H2), 4.104.35 (m, 2  H, Ctf2CH3X 4.40- 
4.45,4.59-4.62 (m, 1 H, H5); *H NMR (250 MHz, C7Dg, 90 ‘Q  8 0.94 («, 3 H. Me), 0.96 (J, 3 H, Me). 1.06 (t, J  « 7.1 Hz, 3
H, CH2CHj), 1.17 (d, /  -  12.8 Hz, 1 H, 1.65 (dd. J  -  8.0,12.7 Hz, 1 H, H ó ,^ , 1.79 (ddd, J m 2.8,6.5,1X7 Hz, 1 H,
H4), 2.03 (dt, J  = 3.0,10.7 Hz, 1 H, H4), 3.10-3.20 (m, 2 H, N O ty . 3.90-4.10 (m, 3 H, C02C//2CH3 and H3), 4.084J8 (m. 1
H, H5); I3C NMR (50 MHz) 8  (all signals appear as rotamers) 14.5,14.7 (CH2CH3), 22.5, 22.6 (Me). 31.1, 31.3 (Me). 40.2,
40.4 (C4), 43.9, 44.5 (C6 ), 49.5 (C3), 54.7, 55.4 (C5), 56.7, 57.5 (C2), 61.2, 61.6 (CH2CH3), 64.7, 65.7 (C7), 153.0, 153.7 
(C(0)); ,3C NMR (50 MHz, C6D6, 65 *C) 8 15.5 (CH2CH3), 22.4 (Me), 32.4 (Me). 41.5 (C4). 45.1 (C6). 51.0 (C3). 56.3 (C5).
58.5 (C2), 61.9 (CH2CH3), 65.5 (C7), 153.0 (C(0)); MS (El, 70 eV) nU  (relative intensity) 246 (M+, 40), 211 (100), 142 (32), 
128 (36), 70 (18); HRMS calcd for Cj ^ j g N ^ C l 246.1135, found 246.1129.
/W -(3 # , 5 5 )»3 -C h lo ro -l,8 -diaz&-3 ,7 ,7 -trim etliyIbicycl0 [3 *2 . 1 ]octaiie-8 -carboxylic acid methyl ester (46).
According to the general procedure, 38 (228 mg, 0.89 mmol) dissolved in CH2CI2 (9 mL) was cyclized by using TiCI^  (1.48 mL 
of a 1.2 M solution, 1.78 mmol). After being stirred at rt for 18 h, the reaction was worked-up and the residue was chromatographed 
(ethyl acetate/hexane 1:1) to give an inseparable mixture (153 mg) of 46 (56%) and 1 ,8 -d la z a -3 ,7 ,7*  
trim ethylb icyclo[3.2 .1]oct-2-ene-8-carboxyIic acid methyl ester (47) (16%) as a colorless oil, fly 0.37. 46 
(mixture): IR v 1690; *H NMR (200 MHz) 8 (some signals appear as rotamers) 1.08-1.62 (m, 9 H, 3 x Me), 1.90-2.12 (m, 2 H, 2 
x H6), 2.33-2.36 (m. 1 H, H4), 264 (d, Jm  12.8 Hz, 1 H, H4), 3.36 (d, J * 16.3 Hz, 1 H, H2), 3.72 (s, 3 H, C02CH3), 3.76 (d, 
J  = 16 Hz, 1 H. H2), 4.35-4.55 (m, 1 H. H5); 13C NMR (50 MHz) 8 25.7 (Me), 31.8 (Me), 37.0 (Me), 40.7 (C6), 41.5 (C4), 52.6 
(C02CH3), 52.8 (C5), 63.1 (C2), 65.9 (Cl), 66.9 (C3), 155.0 (C(0)). 47: IR v 1680; !H NMR (200 MHz) 8 1.15 (*, 3 H, Me),
I.33 (s, 3 H. Me). 1.58 (s ,3 H, Me), 1.50-1.70 (m,2 H, H4 andHó^aQ. 2.08(d d ,/«  11.8,8.0 Hz. 1 H, H ó^o).2.60 (m, 1 H, 
H4), 3.73 (s, 3 H, C 02CH3), 4.40-4.50 (m, 1 H, H5). 6.10-6.14 (s, 1 H, H2); ]H NMR (250 MHz, C6D6, 65 ”Q  8 1.09 (s, 3 H, 
Me), 1.14 (s, 3 H, Me), 1.20(dd,J« 12.3.5.4 Hz. 1 H, 1.15-1.25 (m, 1 H,H4), 1.28 (s, 3 H, Me). 1.79 (d d ,/-  12.2,
7.9 Hz, 1 H, H66X0), 2.56 (d. /  = 15.7 Hz, 1 H, H4). 3.54 (s, 3 H. C02CH3). 4.46 (br s. 1 H. H5), 6.04 (j, 1 H, H2); 13C NMR 
(50 MHz) 5 (some signals appear as rotamers) 19.6 (Me), 24.2 (Me), 29.3 (Me), 37.3, 37.6 (C4), 45.5, 46.2 (C6), 52.6
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(CO2 CH3), 53.6 (C5), 73.2 (07), 124,7 (C3), 134.8 (C2), 154.6 (C(O)); MS (El, 70 eV) mil (relative intensity) 210 (M+, 11), 
154 (67), 153 (70), 109 (56), 95 (100); HRMS calcd for Cn H18N20 2  210.1368, found 210.1322.
re/-(35,4jR ,55)-3-C1iloro*lt8*dUz&-4,7|7-trimethylblcycl<}[3.2.1]octaiie-ft-carbo>cylic acid ethyl ester (48). 
Following the general procedure, 39 (145 mg, 0.54 mmol) was cyclized with TÍCI4  (0.92 mL of a 1,2 M solution, 1.11 mmol) in 
CH2Cl2 (5 mL). Work-up and fc (ethyl acetate/hexane 2:1) afforded 48 (67 mg, 0.26 mmol, 53% (after correction)) as a colorless 
oil. fly 0.50. IRv 1690; !H NMR (200 MHz) 5 1.03 (d. /  « 6.7 Hz. 3 H. CHCW3). 1.18 (s. 3 H. Me), 1.30 (t, /  » 7.0 Hz. 3 H, 
CH2C//3). 1.36 (s. 3 H, Me), 1.63 (d, /  -  12.7 Hz. 1 H. H6^ J , 1.88 (dd, J  -  12.7, 8.0 Hz. 1 H, H Ó ^ . 2.12 (m, 1 H. H4). 
3.10 (d d ,/*  14 .4 ,11.2Hz, 1 H. H2- ,) , 3.42 (dd,/*  5.9,11.1 Hz. 1 H. H2eq), 3.76 (dt,/ » 6.3.10.8 Hz. 1 H, H3),4.26 (m, 2
H, CW2CH3), 4.35 (m, 1 H, H5); NMR (50 MHz) 8  (all signals appear as rotamers) 14.6, 14.8 (CH2 CH3), 14.9, 15.4 
(CHCH3), 22.5,22.6 (NCCH3), 31.2,31.3 (NCCH3), 39.8,40.4 (C6), 42.8,43.1 (C4), 56.7,57.5 (C2). 57.6,57.7 (C5). 59.4, 
60.1 (C3). 61.2, 61.8 (C H jO ty, 64.6, 65.6 (C7), 152.8. 153.2 (C(0)); MS (El. 70 eV) mil (relative intensity) 260 (M*\ 37). 
225 (100), 215 (7). 187 (6 ). 171 (13), 142 (27), 128 (33), 70 (19); HRMS calcd tor C ^ H ^ N ^ C l260.1292, found 260.1284.
rf/-(3ft,4S)-3-(l-C hloro-l-m ethylethyI)*l,7'd iaza*6,6-dlniethy1»bicyclo[2.2'l]heptane-7-carboxylic acid 
methyl ester (49). To a solution of 40 (141 mg, 0.52 mmol) in CH2CI2  (5 mL) was added T1CI4 (0.87 mL of a 1.2 M 
soluuon, 1.04 mmol) according to the general procedure F. After being stirred at rt for 18 h, the reaction mixture was worked-up and 
purified by fc (ethyl acetate) to afford 49 (84 mg, 0.32 mmol, 84% (after correction)) as a light yellow oil, /?ƒ 0.35. IR v 1690; H^ 
NMR (200 MHz) 5 1.23 (s, 3 H, Me), 1.24 (s, 3 H( Me), 1.43 (s, 3 H, Me). 1.54 (s, 3 H, Me), 1.69 (d» /*  9.3 Hz, 1 H, H S j^ ,  
1.76 (dd, J * 4.9, 11 5 Hz, 1 H, H5exo), 2.02-2.20 (m, 1 H, H3), 2.65-2.80 (m, 1 Ht H2), 3.25-3.40 (m, 1 H, H2), 3.70 (s, 3 H, 
C02CH3), 4.53 (d, /  -  5.1 Hz, 1 H, H4); I3C NMR (50 MHz) S (all signals appear as rotamers) 25.1,25.2 (Me), 28.6,29.0 (Me), 
301, 30.2 (Me). 30.4, 30.5 (Me), 46.3, 47.1 (C5). 52.6, 53.0 (C02CH3), 53.1, 53.8 (C2), 57.4, 57.9 (C4), 61.3, 61.8 (C3), 
66.5, 66.7 (C6), 70.5,70.6 (CO), 153.4 (C(0)), MS (El, 70 eV) m/z (relauve intensity) 260 (M+, 19), 225 (25), 212 (18). 204 
(46). 169 (30), 141 (21). 127 (100), 83 (42); HRMS calcd for C^H^OjNjCl 2601292, found 260.1292.
3‘Chloro‘l,8-diaza-7»7-dim ethylbicyclo[3.2.1]oct-3-ene-8-carboxylic acid ethyl ester (50). A solution of 41 
(201 mg, 0.79 mmol) in CH2Cl2 (8 mL) was treated with T1Q4 (1.32 mL of a 1.2 M solution, 1,58 mmol) according 10 the 
general procedure F. After being stirred at rt for 18 h, the reacuon was worked-up and purified by fc (ethyl acetate/hexane 1:1) to 
afford 50 (46 mg, 0.19 mmol, 24%) as a yellow oil, Rj- 0.69. IR v 1690; NMR (200 MHz) 5 1.18 (s, 3 Ht Me), 1.28 (t, J  =
7.0 Hz, 3 H, CH2CW3), 1.39 (s, 3 H, Me). 1.95-2.10 (m, 2 H, 2 x H6)t 3.49 (d, J  -  18.1 Hz, 1 H, H2), 3.95 (d, /  -18.2 Hz, I H, 
H2), 4.25 (q, J  = 7.1 Hz, 2 H, a / 2CH3), 4,50-4.75 (m, 1 H, H5), 6.15 (d, J  * 5.5 Hz, H4); l3C NMR (50 MHz) S (some signals 
appear as rotamers) 14.6 (CH2 CH3), 26.1, 26.3 (Me), 32.1 (Me), 49.7, 49.8 (C6), 54.4 (C5), 61.7 (CH2CH3), 61.8, 61.9 (C2),
67.9 (07), 128.8 (C4), 150.3 (C3), 153 0 (C(0)); MS (El, 70 eV) mtz (relaUve intensity) 244 (M+ 90), 208 (61), 187 (39), 152 
(37), 143 (38), 121 (57), 115 (100), 80 (44), 65 (22), 58 (33), 41 (33); HRMS calcd for Cn H17N202Cl 244.0979, found 
244 0981
l,8-Diaza*7,7-dim ethyl-3-ntethylenebicyclo[3.2.1]octane-8-carboxyllc acid ethyl ester (51). To a solution of 
42 (101 mg, 0.32 mmol) in CH2 Cl2  (4 mL) was added BF3 *OEt2  (79 *iL, 0.64 mmol) at 0 *C. The reaction mixture was stined at
0 ‘C for 15 min and 2 h at rt, poured into aq satd NaG (40 mL) and extracted with CH2CI2 (3 x 40 mL). The combined organic 
layers were dried (MgSO^), filtered and concentrated in vacuo. Purification of the residue by fc (ethyl acetate/hexane 1:1) afforded 51 
(43 mg, 0.19 mmol, 61%) as a colorless oil, R j  0 32, IR v 3070, 1690; H^ NMR (200 MHz) 5 (all signals appear as rotamers)
1.04, 1.09 (s, 3 H, Me), 1 20-1.32 (m, 3 H, CH2C//3), 1.33 (s, 3 H, Me), 1.64, 1.66 (d, / -  12.3 Hz, 1 H, H Ó ^ ,  1.75-2.15 
(m, 2 H, Hó^o and H4), 2.50-2,70 (m, 1 H, H4), 3.45-3.70 (m, 2 H, 2 x H2), 4,11-4.23 (m, 2 H, Cff2CH3), 4.47-4.65 (m, 2 H, 
H5), 4 88 .4.93 (s. 2 H, =CH2); 'h  NMR (250 MHz, C7 Dg, 9 0 ' Q S  1.02 (s, 3 H, Me), 1.10 (t, / »  7.1 Hz. 3 H. CHjOTj).
1 12 (s. 3 H. Me). 1.42 (d ./  = 14.3 Hz, 1 H, H6,^aJ, 1.71 (d d ,/-  7.7,12.1 Hz, 1 H, H e^ J , 1.85 (d ,/=  14.3 Hz, 1 H, H4),
2 58 (d, / =  14 I Hz, 1 H, H4), 3 31 (d, /  « 7.7, 12.1 Hz. H2), 3.61 (d. /  -  15.6 Hz. 1 H, H2). 4.03-4.15 (m, 2 H, C/ijCHj), 
4.45-4.60 (m, 1 H, H5). 4.63-4.65 (m, 2 H, -CH2); 13C NMR (50 MHz) 8  (some signals appear as rotamers) 14.8 (CH ^Ity.
22.8 (Me). 31 4.31.5 (Me), 39.4,39.6 (C4). 43.7,44.3 (C6), 54.9,55.6 (C5). 56.5,57.3 (C2). 61.2,61.3 (CttjCH^, 66.5 (C7), 
113 8,114.0 (=CH2). 140 8,141.0 (C3), 154.5 (C(0)); MS (El, 70 eV) m/z (relative intensity) 224 (M+. 93), 209 (24). 168 (38),
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151 (100), 137 (42), 109 (32), 95 (25), 81 (17); HRMS calcd for C ^ H ^ C ^  224.1525, found 224.1530.
l,7-D iaza-5,5-dim ethyl-3-ethenyIldeM ebicyc!o[2.2.1]heptane-7-carboxylic acid m ethyl ester (52), T oa  
soluuon of 43 (109 mg, 0.37 mmol) in CH2Cl2 (4 mL) was added BFj-OE^ (91 pL, 0.74 mmol) at 0 *C. The reaction mixture 
was stirred at 0 *C for 15 min and for 18 h at rt. The resulting orange solution was poured into aq satd NaCl (50 mL) and extracted 
with CH2C12 (3 x 50 mL). Hie combined organic layers were washed with H2O (50 mL), dned (MgSO^, filtered and concentrated 
in vacuo. The residue was chromatographed (ethyl acetate/hexane 1:1) to give 52 (48 mg, 0.23 mmol, 62%) as a colories* oil, Rj 
0.36. IR v 1980,1960,1690. 890, 840; XH NMR (200 MHz) S 1.23 (*. 3 H, Me), 1.24 (s, 3 H, Me), 1.51 (d, 7 -1 1 .3  Hz, 1 H, 
HS^aQ, 1.94 (d d .7 -4 .7 .11.9 Hz, 1 H. 1 1 5 ^ , 3.57 (dt,/-1 5 .1 ,4 .7  Hz. 1 H.H2), 3.74 («. 3 H, COjCH-j), 3.81 (dt, /  » 15.1,
3.1 Hz, 1 H, H2), 4.83 (br j, 2 H, - O t y ,  4.88 (d, J  -  4.7 Hz, 1 H, H4); 13C NMR (50 MHz) 8 24.9 (Me). 30.6 (Me), 46.3 (C5),
53.0 (CO2CH3), 54.3 (C2). 64.9 (C6 ), 65.0 (C4), 79.3 (-CH2), 100.8 (C-C-CHj), 156.0 (C(0)), 197.1 (C-C-CHj); MS (El, 70 
eV) m/z (relative intensity) 208 (M+, 82), 193 (14). 152 (100), 141 (74), 125 (30), 107 (16). 97 (20), 70 (8); HRMS calcd for 
C11HI6N2°2 2081212, found 208.1205.
Cyclization product 53. To a solution of44 (1.57 g, 4.59 mmol) in CH2C12  (50 mL) was added at 0 *C BFj OEtj (2.26 mL.
18.4 mmol). The mixture was surrcd at 0 *C for 10 min and for 18 h at rt The mixture was poured into aq said NaCl (100 mL) and 
extracted with CH2Cl2  (3 x 100 mL). The combined organic layers were dried (MgSO^, filtered and concentrated in vacuo. The 
residue was chromatographed (ethyl ace tate/hexane 1:1) to give 53 (1.44 g, 4.86 mmol, 94%) as a colorless oil that solidified upon 
standing, mp 106-107 ‘C (ethyl acetate/hexane). R ,  0.36. IR v 1720,1645,1420,1370,1290; NMR 8  1.22 (s, 3 H, Me), 1.34 
(s, 3 H, Me), 1.63 (s, 3 H. Me), 1.66 (s, 3 H, Me), 1.98 ( d , / -  115 Hz, 1 H, H6endo), 2.12 (dd, J  -  6.0, 12.0 Hz, 1 H,
3.44 (d. /  = 18.9 Hz. 1 H, H2). 3.76 (s. 3 H, COjCHj), 3.90 (brd. /  -  19 Hz. 1 H, H2), 5.10 (br s, 1 H. H5); 13C NMR S (some 
signals appear as rotamers) 23.2,25.8,26.5,32.1 (Me), 49.7,50.3,51.2 (hr, C2 and C6), 51.7 (C5), 53.1 (CO2CH3), 66 .8 , 67.6 
(C7), 107.1,107.6 (OCO and C4). 155.0,158.3,161.7 (C3 and 2  x C(0)); MS (El, 70 eV) m/z (relative intensity) 296 (M+, 15). 
238 (100), 210 (30), 155 (66), 109 (25), 80 (12); HRMS calcd for C14H20N2O5  296.1372, found 296.1369; Anal. Calcd for 
C14H20N2°5: c * 56.76; H, 6.76. Found; C, 56.35; H, 6.76.
/‘ffN(3J?,5£)-l,8<’DÍaxa-3-(form yIoxy)-3,7>7-trlraethylbÍcyclo[3.2.1]octane-8-carboxyUc acid methyl ester 
(56). A solution of 38 (232 mg, 0.91 mmol) in HCOOH (9 mL) was stirred at 50 *C for 18 h. Concentration in vacuo and fc 
(ethyl acetate/hexane 1:1) afforded 56 (85 mg, 0.33 mmol, 37%) as a colorless oil, Rf 0.20 and 47 (65 mg, 0.31 mmol, 34%) as a 
colorless oil, Rf0.34. 56: IR v 1720,1680; *H NMR (200 MHz) 5 (some signals appear as rotamers) 1.07 (s, 3 H, Me), 1.43 (s,
3 H, Me), 1.47 (s, 3 H, Me), 1.91-2.13 (m, 3 H, 2 x H6  and H4), 2.51 (d,/ » 15.2 Hzr 1 H, H4), 3.16 (d, / « 16.2 Hz. 1 H, H2), 
3.74 (s, 3 H, CO2CH3), 3.79 (d, /  -  16.2 Hz, 1 H, H2), 4.35,4.46 (br s, 1 H, H5); *H NMR (250 MHz, C6D6, 65 *C) 8 1.05 (s,
3 H, Me), 1.11 (*, 3 H, Me), 1.23 (s, 3 H, Me). 1.65 (dd. /  -  7.9,12.3 Hz, 1 H, H6W0), 1.82 (d, /  -  11.1 Hz, 1 H, 1.87
(d, /  * 16.7 Hz. 1 H. H4). 2.23 (d, /  « 15.0 Hz, 1 H. H4), 3.12 (d. / -  16.3,1 H, H2), 3.55 (s. 3 H. CO2CH3), 3.59 (d. /  « 16.3 
Hz, 1 H, H2), 4.20-4.40 (m, 1 H, H5), 7.50 (s, 1 H, CHO); NMR (63 MHz) 8 (some signals appear as rotamers) 23.2 (Me), 
27 4 (Me), 31.7 (Me), 40.9 (C6), 41.8,42.5 (C4), 52.1,52.4 (CO2CH3), 52.8,52.9 (C5), 58.7,59.4 (C2), 65.3,65.7 (C7), 78.7 
(C3), 155.0, 159.8 (C(0)); MS (El. 70 eV) m/z (relative intensity) 256 (M+. 25). 227 (59). 154 (31). 143 (29). 129 (60), 128 
(100), 95 (43). 70 (64); HRMS calcd for C ^ H jq N ^  256.1423, found 256.1407.
rt/-(3#,45)-l,7-Diaza-6,6«dim ethyl-3'-[dim ethyl(forinyloxy)m ethyl]bicycIo[2.2J]heptane-7-carboxyUc acid 
methyl ester (57). A solution of 40 (142 mg, 0.52 mmol) in HCOOH (5 mL) was stirred at 50 *C for 18 h. Concentration in  
vacuo and fc (ethyl acetate/hexane 1:1) afforded 57 (118 mg, 0.44 mmol, 84%) as a yellow oil, Rf 0.14. IR v 1715; *H NMR (200 
MHz) 5 (all signals appear as rotamers) 1.09-1.20 (m, 7 H, 2 x Me and H5^ q ), 1.39 (s, 3 H, Me), 1.42 (s, 3 H, Me), 1.72, 1.70 
(dd,/ = 4.9,11.5 Hz, 1 H. H5 ^ ,  2.05, 2.14 (t, /  » 7.4 Hz, 1 H, H3), 2.70,2.73 (dd. /  * 6.5,13.0 Hz, 1 H, H2), 3.22,3.24 (dd, 
/  = 8.0,12.6 Hz, 1 H, H2), 3.62, 3.67 (C02CH3), 4.45,4.51 (d, /  -  5.0 Hz, 1 H, H4), 7.86, 7.87 (s, 1 H, OCHO); *H NMR 
(250 MHz, C7Dg, 90 *C) 6  0.88 (d, /  -  11.3 Hz, 1 H, H S ^ .  0.93 (s, 3 H. NCCH3), 1.05 (s, 3 H, NCCH3), 1.25 (s. 3 H. 
CHCCff3), 1.29 (s, 3 H. CHCCW3), 1.52 (dd. /  * 5.0,11.3 Hz, 1 H, HS^q), 1.96 ( t , /  = 7.3 Hz. 1 H. H3). 2.60 (d d ,/-  6 .8 ,12.6 
Hz, 1 H, H2), 2.98 (dd, /  -  7.9,12.6 Hz, 1 H, H2), 3.48 (s, 3 H, C02CH3), 4.43 (d, /  -  4.9 Hz. 1 H, H4), 7.61 (s. 1 H, OCHO); 
l3C NMR (50 MHz) 8 (all signals appear as rotamers) 23.1,23.5 (Me). 23.6,24.0 (Me), 25.0,25.1 (Me), 30.4,30.5 (Me), 46.5,
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47.4 (C5), 51.7. 52.1 (C2), 52.4, 52.6 (C3), 53.7, 54.5 (C4), 60.6, 61.4 (CO2 CH3), 65.9, 66.6 (C6), 83.4. 83.5 (CO). 153.7,
159.6.160.0 (C(0)); MS (El, 70 eV) mix (relative intensity) 270 (M+, 15), 225 (16), 168 (100), 153 (47), 141 (72), 127 (81), 123 
(41), 109 (32), 83 (38), 59 (45), 41 (89); HRMS calcd for 270.1580, found 270.1581.
1.8-Diaza-7,7*d(metliylbicycIo[3.2.1]octaii*3*one*8«carboxyHc acid ethyl ester (58). A solution of 4 1 (134 mg, 
0.53 mmol) in HCOOH (5 mL) was stirred at 50 *C for 20 h. After addition of H2O (5 mL), the reaction mixture was stirred at 60 
’C for another 6  h and poured into aq satd NaHC0 3  (100 mL). An additional amount of NaHCOj was added until the water layer 
reached pH * 9. After extracuon with CH2 CI2 (3 x 100 mL), the combined organic layers were dried (MgSO^, filtered and 
concentrated in vacuo. fc (ethyl acetate/hexane 1:1) afforded 58 (56 mg, 0.25 mmol, 47%) as a light yellow oil, R j 0.28. IR v 
1720, 1690; *H NMR (200 MHz) 8 1.18 (s, 3 H, Me), 1.61 (I, J -  6.9 Hz, 3 H, CH2C//3), 1.61 (s, 3 H, Me), 1.69 (d, J -  12.8 
Hz, 1 H, He^do), 2.24 (dd, 7 -7 .8 ,1 2 .8  Hz, 1 H, H6 KO), 2.42 (d, J  -  16.6 Hz, 1 H, H4), 2.78 (dd, J  » 3.2,16.3 Hz, 1 H, H4), 
3.63 (s, 2 H, 2 x H2), 4.28 (q, J  -  6.9 Hz, 2 H, Ctf2CH3), 4.75-5.00 (m, 1 H, H5); 13C NMR (50 MHz) 8 14.8 (CH2 CH3), 24.8 
(Me), 31 2  (Me), 45.9 (C6), 48.5 (C4), 54.8 (C5), 62.3 (CH2CH3), 62.9 (C2), 67.5 (C7), 154,0 (NC(0)), 208.2 (C(0 )); MS (El, 
70 eV) m/z (relative intensity) 226 (M+, 12), 198 (84), 157 (31). 143 (100), 71 (26); HRMS calcd for C jjH jgN ^  226.1305, 
found 226 1311.
1.8-Diaza-7,7-dimethyl-3-methylenebicyc1o[3.2.1]octane~8-carboxylic acid ethyl ester (51). A solution of 42 
(2.50 g, 7.97 mmol) m HCOOH (80 mL) was stirred for 18 h at rt ConcentraUon in vacuo and fc (ethyl acetate/hexane 1:1) afforded 
51 (1 52 g, 6 8 mmol, 85%) as a yellowish oil, fly 0.32.
1.7-Diaza-5»5-dimethyl-3-ettienylidenebicyclo[2.2.1]heptafie-7*carboxylk acid methyl ester (52). A solution 
of 43 (96 mg, 0.45 mmol) in HCOOH (5 mL) was stirred at 50 *C for 18 h. Concentration in vacuo and fc (ethyl acetate/hexane 
1:1) afforded 52 (28 mg, 0.13 mmol, 42%) as a colorless oil, R j0.36.
1.8-Diaza-7,7*dimethy)bicyclo[3<2.1]octan-3-one-8-carboxyllc acid methyl ester (59). A solution of 44 (77 mg, 
0.23 mmol) was stirred in HCOOH (2 mL) at 100 'C for 5 h. ConcentraUon in vacuo and purification by fc (ethyl acetate/hexane 
1:1) afforded 59 (15 mg, 0.066 mmol, 29%) as a colorless oil, R , 0.28. IR V 1720, 1690; *H NMR (200 MHz) 8 1.18 (s, 3 H, 
Me), 1.61 (s, 3H , Me), 1.69 (d.J -  12.8 Hz, 1 H, H6^ Q , 2.24 (dd, J  -  7.8,12.8 Hz, 1 H, 2.42 (d, J  « 16.6 Hz, 1 H, 
H4), 2.78 (dd. 7 = 3 2,16.3 Hz, 1 H. H4), 3.63 (s, 2 H, 2 x  H2), 3.76 (s, 3 H. C02CH3), 4.75-5.00 (m, 1H. H5).
rf/-(35 ,5S )‘3-Ch]oro-l,8-diaza-7,7-dim ethylbIcycIo[3.2.1]octane (60). To a solution of 45 (65 mg, 0.27 mmol) in 
MeCN (3 mL) was added Me3SiI (0.11 mL, 0.80 mmol) and the reaction mixture was stirred at 40 *C for 2 h. The resulUng dark 
brown soluuon was poured into aq NaHS0 3  and extracted with C ^ C ^  ( 3 x 2 0 mL). The combined organic layers were dried 
(MgSO^, filtered and concentrated in vacuo. The residue was chromatographed (acetone) to yield 60 (37 mg, 0.21 mmol, 79%) as 
white crystals, mp 44.5-45 *C, Rr 0.35. IR v 3300; [H NMR (200 MHz) 8  1.13 (s, 3 H, CH>rft), 1.42 (s, 3 H, Me^ Q . 1.67 
(d, 1 H, J  -  129 Hz. 1.89 (dd, 1 H. J = 12.9, 7.6 Hz. H6ex0), 2.12 (m. 2 H, H4). 3.20 (dd, J  -  11.1, 14.0 Hz, 1 H,
H2gx), 3 35 (dd, J  = 6.2, 14.0 Hz, 1 H, H2a}), 3 60 (m, 1 H, H5). 3.79 (br s, 1 H, NH), 4.20 (tl, J -  11.1,6.3 Hz, 1 H, H3); 13C 
NMR (50 MHz) 8 22.9 (Me), 31.9 (Me), 42.2 (C4), 45.3 (C6), 50.9 (C3), 57.7 (C5), 58.1 (C2), 65.6 (C7); MS (El, 70 eV) m/z 
(relative intensity) 174 (M+. 52), 143 (5). 139 (100), 118 (24), 111 (76), 70 (75), 67 (35), 56 (32), 41 (31); HRMS calcd for 
C8H15N2C1174.0924, found 174.0931.
rt/-(35,55)-3»C hloro-l,8-diaza-7,7,8-trim ethylbicyclo[3.2.1]octane (61). To a solution of 60 (50 mg, 0.33 mmol) 
in McCN (I mL) were added 37% aq formaldehyde (130 nL, 1 66  mmol) and NaB^CN (33 mg, 0.53 mmol). After being stirred for 
15 mm at it, a few drops of glacial aceUc acid were added carefully unUl the pH was neutral. Stirring was continued for 45 min, 
while the pH was kept neutral by dropwise addition of glacial acetic acid. The soluuon was poured into 1 N KOH (10 mL) and 
extracted with CH2 Cl2 (3 x 20 mL). The combined organic layers were washed with H2O (10 mL), dried (K2CO3), filtered, 
concentrated in vacuo and chromatographed (ethyl acetaic^exane 1:1) to afford 61 (45 mg, 0.27 mmol, 82%) as a colorless oil, R j 
040. IR v 1455, 1260, 900, 635. 'h  NMR (200 MHz) 8  1.28 (s, 3 H, Me). 1.33 (*. 3 H. Me). 1.56 (d. J  ■ 13.1 Hz. 1 H, 
H6cndo>, 1-85-1.90 (m, 1 H, H6exo), 2.10 (dd, J = 12.6, 7 7 Hz, 1 H, H4). 2.23 (dd, J = 13.1,2.4 Hz, 1 H, H4). 2.68 (s, 3 H.
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NCH3), 3.00 (dd, J  * 6.4,14.9 Hz, 1 H, H2). 3.25 (dd, J  -  11.3,14.9 Hz, 1 H, H2), 3.30-3.40 (m, 1 H, H5), 4.28 (tt, /  « U .l, 
6.8 Hz. 1 H, H3); ,3C NMR (63 MHz) 5 22.8 (Me). 293 (C6), 31.0 (Me), 317 (Me), 42.9 (C4). 47.8 (C3), 52.4 (C2), 58.1 (C5).
73.9 (C7); MS (El, 70 eV) mlz (relative intensity) 188 (M+, 18), 133 (100), 97 (35), 43 (42); HRMS calcd for CgH ^N ^l 
188.1081, round 188.1077.
1.8-D iaza-7,7-dlm ethyl-3-toethyIenebicyclo[3.2,l]ocU ne (62), A solution of 51 (78 mg, 0.35 mmol) and KOH (78 
mg, 1.4 mmol) in MeOH (4 mL) was heated at reflux temperature for 90 h. The resulting solution was poured into aq satd NH4CI 
(25 mL) and extracted with CH2CI2 (3 X 20 mL). The combined organic layers want dried (MgS0 4 )t filtered and concentrated in 
vacuo. Purification of the residue by fc (acetone) afforded 62 (21.5 mg, 0.14 mmol, 40%) 15 a colorless oil, Rf 0.10. IR v 3300, 
3060,895; JH NMR (200 MHz) 5 1.11 (s, 3 H, Me), 1.38 (*. 3 H, Me), 1.66 (d, /  -  1Z0 Hz, 1 H, 1.80 (ddd,/ = 0.7,
7.1,12.4 Hz, 1 H, 2.10 (d, J  * 13.9 Hz. 1 H, H4), 2.68 (d, J  -  13.3 Hz, 1 H, H4). 3.49 (d. J  -  15.4 Hz, 1 H, H2), 3.60- 
3.80 (m, 2 H, H2 and H5), 3.93 (br s, 1 H, NH), 4.7J-4.85 (m, 2 H. -CHj); 13C NMR (63 MHz) 8  23.1 (Me), 32j0 (Me), 41.0 
(C4), 45.4 (C6), 57.4 (C5), 57.7 (C2), 66.4 (C7). 112.3 (»O ty , 142,7 MS O3 *70  tY > '"/l (rd«*ve intensity) 152 (M+, 
33), 137 (100), 109 (13). 95 (26), 81 (25), 69 (40), 55 (25), 41 (32); HRMS calcd for C j H ^  152.1313, found 152.1310.
1.8-Diaza-3-methy]ene«7,7,8*trlmethylbicycIo[3*2.1]oct&ne (63). To a suspension of LiAlIfy (17 mg, 0.45 mmol) in 
THF (2 mL) was added drop wise a solution of 51 (51 mg, 0.23 mmol) m THF (2 mL) and the mixture was heated at reflux 
temperature for 3 h. After cooling to rt, H2O (53 mL) was added and the resulting suspension was washed with ether (50 mL). The 
organic layer was dried (MgSCfy), filtered and concentrated in vacuo to afford 63 (9.8 mg, 0.059 mmol, 13%) as a colorless oil, Rf 
(ethyl acetate) 0.10. IR v 3060, 890; *H NMR (200 MHz) 8 1.27 (s, 3 H, Me), 1.32 (s, 3 H, Me), 1.62 (d, J  « 12.1 Hz, 1 H, 
^endo), 1.89 (d. J  = 14.9 Hz, 1 H, H4), 2.06 (dd, /  ■ 7.4, 111 Hz, 1 H, » 6^ .  2.73 (s, 3 H, NCH3). 2.78 (d. J  * 14.9 Hz, 1 H, 
H4), 3.25 (d. J  -  16.2 Hz, 1 H, H2), 3.36-3.46 (m, 1 H, H5), 3.80 (dd. J  -  1.0,16.2 Hz, 1 H, H2). 4.71-4.84 (m, 2 H, -CHj); 
13C NMR (50 MHz) 8  24.6 (Me), 32.7 (C4), 33.0 (Me), 35.9 (NCH3), 45.9 (C6), 49.1 (C2). 59.8 (C5), 63.9 (C7), 111.3 (-CHj), 
142.6 (C3); MS (El, 70 eV) mlz (relauve intensity) 166 (M+, 57), 151 (95), 125 (26), 111 (17), 95 (27), 83 (100), 82 (90), 55 
(23), 43 (37); HRMS calcd for C10HIgN2  166.1470, found 166.1470.
Diazeplne 64. A solution of 53 (100 mg, 0.34 mmol) in THF (2 mL) was added to a solution of Na (31 mg, 1,35 mmol) in 
NH3 (15 mL) at -78 *C. The mixture was stirred at *78 *C for 3 h, quenched by addition of NH4 CI (182 mg, 3.4 mmol) and the 
ammonia was allowed to evaporate. The residue was dissolved in H2O (20 mL) and extracted with CH2 Cl2 (3 x 20 mL). The 
combined organic layers were dried (MgSO )^, filtered, concentrated in vacuo and chromatographed (ethyl acetatetfiexane4:l) to afford 
53 (12 mg) and 64 (12 mg, 0.040 mmol, 16% (after correction)) as a white solid, mp 157-159 *C, Rf 0.20. IR v 3440, 1720, 
1640,1500,1270; *H NMR (250 MHz) 8 1.17 (s, 3 H, Me), 1.21 (s, 3 H, Me), 1.61 (s, 3 H, Me), 1.65 (s, 3 H, Me), 1.68 (d, J  -
14.9 Hz, 1 H, CHH), 1.77 (br s, 1 H. NH). 2.22 (dd, J  «  7.8,14.9 Hz, 1 H, CHH), 3.44 (d. J »18.7 Hz, 1 H, NCWH), 3.61 (d, J -
18.7 Hz, 1 H, NCHH), 3.65 (s, 3 H. O ^ O ty , 4.86 (br t, /  -  7.8 Hz, 1 H. NCH), 5.70 (br d, J  -  7.8 Hz. 1 H, NH); 13C NMR 
(63 MHz) 8 24.3,25.5,27.8,31.7 (4 x Me), 43.6,44.5 (NC and CH2>.45.0  (NCH), 52.0 (COjCHj), 52.1 (N O ty. 105.3, 107.2 
(OCO and a ) .  155.9.161.1.168.8 (2 x  C(0) and C4); MS (El, 70 eV) mlz (relative intensity) 298 (M*\ 7). 223 (50), 183 (17), 
165 (100), 150 (25), 71 (30). 58 (85).
Hydrazine 65 . To a solution of 53 (700 mg, 2.36 mmol) in MeCN (3 mL) was added Me3$il (403 pL, 2.83 mmol) and the 
mixture was stirred at 40 *C for 2 h. It was poured into aq satd NaHSC  ^ (50 mL) and extracted with CH2C12 (3 x 50 mL). The 
combined organic layers were dried (K2CO3), filtered, concentrated in vacuo and chromatopgraphed (acetone) to afford 65 (550 mg,
2.31 mmol, 98%) as a colorless oil that solidified upon standing, mp 150*160 *C (decomposes before melting),/?ƒ 0.30. IR v 3295, 
1710, 1640, 1420, 1295, 1110, 1030, 890; 'h  NMR (200 MHz) 8  1.21 (s, 3 H. Me). 1.34 (s. 3 H. Me), 1.64 (s. 6  H, 2 x  Me),
1.91 (dd, J *  5 .8 ,12.2 Hz, 1 H, H6exo), 2.06 (d. / =  12.2 Hz. 1 H. He^ Q , 3.41 (d , J ~  18.8 Hz, 1 H. H2), 3.81 (d , /  = 18.7 Hz.
1 H, H2),4 1 6 ( d , /» 5.7 Hz, 1 H ,H 5),4.20(brs, 1 H.NH); 13CNMR(50MHz)8 23.3,26.2,26.5,32.6 (Me), 51.5,51.6(C2 
and C6), (53.2 (C5), 66.2 (C7), 106.5 (OCO), 107.9 (C4), 159.0, 1616 (C3 and C(0)); MS (El, 70 eV) mlz (relative intensity) 
238 (M+, 7), 180 (67), 152 (20), 97 (45), 70 (17), 43 (18). HRMS calcd for C12HigN20 3  238.1317, found 238.1313; Anal. 
Calcd forC12H18N20 3 ; C, 60 49; H, 7.61; N, 11.76. Found' C, 60.36; H, 7.72; H, 1169.
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tf-M ethylhydrazine 64. To a solution of 65 (600 mg, 2,52 mmol) in MeCN (6 mL) were added 37% aq formalcfehyde (1.01 
mL, 12.3 mmol) and NaBH^CN (253 mg, 4.03 mmol). After being stirred for 15 min at rt, glacial acetic add was added carefully 
until the pH was neutral. Stirring was continued for 45 min, while the pH was kept neutral by dropwise addition of glacial acetic 
acid. The solution was poured into 1 N KOH (40 mL) and extracted with CH2CI2  (3 x 50 mL). The combined organic layers were 
washed with H20  (30 mL), dried filtered, concentrated In vacuo and chromatographed (ethyl acetate) to afford i f  (570 mg,
2.26 mmol, 90%) as a while solid, mp 64.5-66.5 *C (ethyl acetate), R j  0.20. IR v 1715, 1640, 1415, 1400, 1380, 1370,1290, 
1265,1100; 'h  NMR (200 MHz) 8  1.28 (s, 3 H, Me), 1.38 (s, 3 H. Me). 1.69 (s, 6  H, 2 x Me), 1.94 (d, /  « 11.9 Hz, 1 H. 
H6endo>>Z 3 3  W  J’-  6.1,12.2 Hz, 1 H, H e ^ .  2.66 (*. 3 H. NCHj), 3.31 (d. /  -  19.3 Hz. 1 H, H2). 3.75 ( d . / -  19.2 Hz, 1 H. 
H2). 3.91 (d, /  -  6.0 Hz, 1 H, H5); ,3C NMR (50 MHz) 8  23.7,26.2,27.4,33.6 (4 x Me). 38.8 (NCH3). 56.7 (C5), 65.0 (C7).
105.4,106.4 (OCX) and C4 ), 159.4,161.9 (C3 and C(0)); MS (El, 70 eV) mil (relative intensity) 252 (M+, 30), 194 (100), 166 
(27), 111 (86), 83 (26). 43 (17); HRMS calcd for 0 ^ 2 0 ^ 0 3  252.1474, found 252.1479.
3>B enzoy]oxy-7»7,8-trim ethy!-l,8-diazablcycIo[3.2.1]oct-3-ene»4.carboxylic acid m ethyl e iter  ( « ) .  A 
solution of 66 (13 mg, 0.052 mmol) and MeOH (18 pL, 0.5 mmol) in xylenes (0.5 mL) was heated at 170 *C for 10 min in a 
sealed tube. The mixture was concentrated in vacuo to afford 3-oxo-7,7,8-trim ethyl*l,ft~dIazabicyclo[3.2.1]octane-4- 
carboxylie acid methyl ester (67) (10 mg) as a light yellow oil. !H NMR (200 MHz) 8 1.27 (s, 3 H, Me), 1.35 (i, 3 H. 
Me), 1.86 (d, /  = 11.7 Hz, 1 H, H ^ , ) .  2.27 (d d ,/-  6.2,11.9 Hz, 1 H, H e ^ ,  2.64 (s, 3 H, N O ty , 2.82 (d ,/=  3.8 Hz, 1 H. 
H4). 3.34 (d, / -  19.2 Hz. 1 H, H2), 3.76 (s, 3 H, CO2CH3), 3.82 ( d , / - 19.2 Hz, 1 H, H2), 3.83 (dd,/ »  6.1,3.8 Hz, 1 H.H5). 
The crude residue was dissolved in CH2CI2 ^  m^) *** treated with benzoyl chloride (6.5 |iL, 0.056 mmol) and Et3N (8 yL, 0.057 
mmol) at 0 'C. The mixture was stirred at 0 *C for 10 min and 5 h at rt and concentrated in vacuo. fc (ethyl acetate^exane 4:1) 
afforded6 8  (12 mg, 0.036 mmol. 70%) as a colorless oil, R , 0.35. 'h  NMR (200 MHz) S 1.39 (s, 3 H, Me). 1.45 (s, 3 H. Me),
2.01 (d ,/=  11.8 Hz, I H ,H6),2.30(dd ,/ - 6.5,11.8Hz. I H. H6) ,2.74 (s .3 H,NCH3), 3.45(d./ -  19.7Hz. I H, H2).3.59 (s,
3 H, C02CH3), 3.82 (d, /  -  19.9 Hz, 1 H, H2), 4.04 (d, / -  6.5 Hz. 1 H, H5), 7.40-7.60 (m, 3 H, ArH). 8.06-8.11 (m, 2 H. ArH); 
13C NMR (63 MHz) 8  26 6 , 33.1 (2 x  Me), 36.5 (NCHj), 45.6 (C6), 51.2 (C2), 51.7 (CO2CH3). 59.7 (C5), 65.3 (C7). 120.0 
(C4), 128.6,129.8,133.7 (ArH), 128.9 (AiC), 152.0 (C3). 164.0,164.2 (C(0)); MS (El. 70 eV) m/x (relative intensity) 330 (M+. 
20). 169 (20). 105 (100), 77 (21); HRMS calcd for 330.1580, found 330.1579.
(3*Hydroxy-7»7,8«triraethy]-l,8-diazabicyclo[3.2.1]octane-4-carboxylic acid methyl ester (69). A solution of 
66 (13 mg, 0.052 mmol) and MeOH (18 |iL, 0.5 mmol) in xylenes (0.5 mL) was heated at 170 *C for 10 min in a sealed tube and 
concentrated in vacuo to afford 67 (10 mg) as a light yellow oil. The crude residue was dissolved in MeOH (1 mL) and treated at 0 
’C with NaBH4 (12 mg, 0.32 mmol). After being stirred at 0 ‘C for 3 h, the solution was poured into H20  (5 mL) and extracted 
with CH2CI2  ( 3 x 5  mL). The combined organic layers were dried (MgSO^, filtered, concentrated in vacuo and chromatographed 
(acetone) to a/foid 69 (9 mg, 0038 mmol, 73%) as a colorless oil, R f  0.30. IR v 3600, 1705,1430, 1290, 1060,900; *H NMR 
(200 MHz) 8 1.35 (s. 3 H, C H j ^ .  1.51 (s, 3 H, 1.98 (dd, /  « 7.8,12.5 Hz, 1 H, H e ^ ,  2.26 (d, /  * 12.5 Hz, 1 H,
H6endo)» 2 -66 &  3 H» NCH3), 3.05 (t, J  * 4 Hz, 1 H, H4), 3.12 (d, J  » 16.2 Hz, H2), 3.43 (dd. J  » 5.3,16.3 Hz. 1 H, H2), 3.47 
(dd, /  = 7.6,2.6 Hz, 1 H, H5), 3.73 (s, 3 H, C 02CH3), 3.79 (br s, I H, OH), 4.09 (t, J  -  4.9 Hz, 1 H, H3); 13C NMR (63 MHz) 
5 24.4, 33 1, 34.9 (3 x Me). 40.2 (C4), 42.8 (C6), 45.2 (C2), 51.9 (C02CH3), 58.5 (C5), 62.6 (C3), 63.2 (C7), 174.3 (C(0>); 
MS (El, 70 cV) mlz (relative intensity) 227 (M+-1,18), 171 (M+-57,36), 122 (25), 105 (100), 77 (37).
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